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Abstract
A review of the literature revealed the need for further analysis of the impact of
advanced electronic health record (EHR) use on medication error rates within US
hospitals. A retrospective cross-sectional patient level analysis using the combined 2009
data from the National Inpatient Sample (NIS), Health Information Management Systems
Society (HIMSS) Analytics, and American Hospital Association (AHA) annual survey
datasets was conducted to study the relationship between advanced electronic health
record use and medication error rates.
A random sample of 1,032,905 patient cases was selected. A total of
301,289 (29.2%) patient cases originated from hospitals with advanced EHR. A total of
550 hospitals were included in the analysis, with 104 (18.9%) reporting use of advanced
EHR. Compared to patient cases from hospitals without advanced EHR, those with
advanced EHR had a lower proportion of medication errors (6.7% vs. 6.3%, p < 0.0001).
There was only a small difference in the assumed direction to begin with, but it remained
when using the propensity score stratification although the association was no longer
viii

statistically significant when using the matched sample. This indicates that the small
statistically significant difference revealed in the initial analyses may have been due to
selection bias. While use of advanced EHRs has great potential for improving a variety of
health and safety matters in the hospital, it is possible that its current implementation has
not evolved enough to have an effect. Technology alone will not solve the problem, but it
can be a part of the solution. We must establish a total systems approach to problem of
patient safety where technology is part of the solution.
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CHAPTER 1
INTRODUCTION
Background and Need
Patient safety has emerged as a central measure of quality in today’s healthcare
environment that has far-reaching impact on various aspects in the continuum of care.
The practice of patient safety has been defined as those practices that reduce the risk of
adverse events related to exposure to medical care across a range of diagnoses or
conditions (Shojania et al., 2001). The Institute of Medicine (IOM) defines patient safety
as the prevention of harm to patients (Berkowitz et al., 2012) and places it under the
overarching umbrella of quality measures in healthcare (Kohn et al., 2000). Emphasis is
placed on the system of care delivery that (1) prevents errors, (2) learns from the errors
that do occur, and (3) is built on a culture of safety that involves health care
professionals, organizations, and patients (Aspden, 2004). The Agency for Healthcare
Research and Quality's (AHRQ) Patient Safety Network website expands upon the
definition of prevention of harm, describing it as freedom from accidental or preventable
injuries produced by medical care (AHRQ, 2007).
IOM conducted a landmark study in 1999 on medical errors and found that
medical errors lead to the deaths of between 44,000 and 98,000 people in US hospitals
each year (JHITA, 2000). The Journal of the American Medical Association gives a more
conservative estimate and states that between 5,000 and 15,000 of those deaths were
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preventable (Gillespie, 2002). One type of medical error is adverse drug events (ADEs),
which are a subset of those injuries associated with errors that occur during the ordering,
administering, dispensing, and monitoring of drugs (Wolfstadt et al, 2008). ADEs
increase morbidity, and health care costs.
In addition to their impact on patient mortality, ADEs exact other significant
costs. They have been estimated to result in higher costs due to additional care
necessitated by the errors, lost income and household productivity, and disability of
between $17 billion and $29 billion per year in hospitals nationwide (JHITA, 2000). The
impact of medication errors is also felt when patients lose trust in the health care system
and when both patients and health professionals experience reduced satisfaction. Patients
who experience a long hospital stay or disability as a result of errors experience physical
and psychological discomfort. Health professionals pay with loss of morale and
frustration at not being able to provide the best care possible. Society bears the costs of
errors as well, in terms of lost worker productivity, reduced school attendance by
children, and poorer population health (Kohn et al., 2000).
A number of factors contribute to medication errors. One of the most challenging
but preventable factors is the decentralized and fragmented nature of the healthcare
delivery system. When patients see multiple providers in different settings, none of whom
have access to complete information, it becomes easier for errors to occur (Kohn et al.,
2000).
Historically, most third-party purchasers of healthcare provided little financial
incentive for health care organizations and providers to improve safety and quality (Kohn
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et al., 2000). Pay for Performance is changing the way Medicare pays for hospital care by
rewarding hospitals for delivering services of higher quality and higher value (Cromwell
et al., 2011). The program is an umbrella term for initiatives aimed at improving the
quality, efficiency, and overall value of health care. In some Pay for Performance models,
payers consider information technology critical to improving the coordination, quality,
and efficiency of care. In such a measure, payers might reward organizations for the use
of an EHR to order prescriptions for their patients, a process that can both lower costs
and improve quality by reducing medication errors (Cromwell et al., 2011).
Many patient safety practices that are tied to information technology, such as use
of simulators, bar coding, computerized physician order entries, and crew resource
management, which have been considered as possible strategies to avoid patient safety
errors and improve healthcare processes. Although not all adverse events in healthcare
are preventable, IOM concluded that many could be avoided through better professional
practices, more effective teamwork, and new technology (Berkowitz et al., 2012). EHRs
that use computerized physician order entry (CPOE) with clinical decision support (CDS)
have been promoted as an effective strategy to prevent the development of a drug injury
defined as an adverse drug event (ADE) (Wolfstadt et al., 2008). CDS is a technology
that provides clinicians with real-time feedback about a wide range of diagnostic and
treatment-related information as they are entering electronic orders. By running
electronic rules in the background, decision support can check for a variety of potential
errors such as drug interactions, patient allergies to prescribed medications, medication
contraindications, and renal- and weight-based dosing. For a number of years,
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organizations such as the Institute of Medicine and Leapfrog have been calling for
implementation of advanced EHRs, and CPOE in particular, (Milstein et al., 2000).
Efforts have been underway for nearly 50 years to implement EHR systems. The
pace of change has greatly accelerated since the passage of the Health Information
Technology for Economic and Clinical Health Act (HITECH) which is part of the
American Reinvestment & Recovery Act (ARRA) of 2009. This is an effort to transform
healthcare delivery through widespread adoption and use of EHR technology.
Meaningful Use is an incentive program authored by the Centers for Medicare &
Medicaid Services (CMS) that provides eligible hospitals and professionals with financial
incentives to implement EHR systems and demonstrate “meaningful use” of certified
systems.
HITECH proposes the meaningful use of interoperable EHRs throughout the
health care delivery system as a critical national goal. The concept of Meaningful Use
rests on five pillars of health outcomes policy priorities, namely: (1) improving quality,
safety, efficiency, and reducing health disparities; (2) engaging patients and families in
their own healthcare, (3) improving care coordination, (4) improving population and
public health, and (5) ensuring adequate privacy and security protection for personal
health information (CMS.gov).
By providing incentives to individual providers for using EHR systems in specific
ways, CMS has motivated a fragmented customer base to behave more like a single
customer with coherent demands. In effect, CMS, as a behind-the-scenes customer, is
driving standardization and the resulting economies of scale and scope in the EHR field
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in the same way that large industry players have been able to standardize and draw value
from IT use in banking, retail merchandising, airlines, food services, and other sectors of
the economy. Understanding that markets are often slow to respond to customer demand,
and that EHR purchasers have limited ability to evaluate the quality of EHR vendor
products prior to purchase, HITECH also created federal certification of EHR products.
This certification gives a degree of assurance to providers and CMS about the quality of
EHR products they purchase (healthit.gov).
The Meaningful Use incentive program was established with three phases: Stage
1, Data Capture and Sharing; Stage 2, Advanced Clinical Processes; and Stage 3,
Improved Outcomes (see Table 1). Stage 1 of the Meaningful Use program focuses
primarily on promoting consistency of documentation in terms of what data should be
captured (content) and how it should be presented (structure). It does not address in detail
how data should be recorded (vocabulary) (healthit.gov). Stage 1 also links
documentation requirements with measurement and decision support requirements to
ensure that the data being captured are more than just a description of observations,
diagnoses, and treatments for future reference; clinicians now had the systems and the
motivation to document in ways that would allow EHR systems to be tools for enhanced
decision-making.
In terms of interoperability of systems, Stage 1 focuses on promoting interorganization electronic transactions that were already gaining acceptance in the market,
such as e-prescribing, lab results delivery, and public health reporting. It also laid the
foundation for new types of transactions, specifically EHR-to-EHR transactions, by
requiring that systems be able to generate electronic record extracts that can be read by
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other systems. The ability to electronically send, receive, and incorporate such extracts
from other EHR systems was left for more advanced stages.
In Stage 2, Meaningful Use requires hospitals and health care providers to meet
more advanced requirements to qualify for incentives during this stage, and specifies
what criteria electronic health records must meet to achieve certification. Specific to
Stage 2, the capability to submit electronic data about immunizations is in the core set of
criteria for eligible professionals (EPs), as are the capability to submit electronic data for
immunizations, reportable laboratory results, and syndromic surveillance. In addition,
two new public health objectives for EPs have been added to the menu set, requiring the
capability to 1) identify and report cancer cases to a cancer registry and 2) identify and
report non-cancer cases to specialized registries.
Stage 2 further refines the notion of system-neutral records by taking EHR-toEHR interoperability further and requiring not just common structures (consolidated
Clinical Document Architecture (CDA)) and common content (problems, labs,
medications, etc.), but use of specific vocabularies as well, such as SNOMED CT,
LOINC, and RxNORM, to enable cross-system understanding of clinical information
from one organization to another. And while Stage 1 simply requires that systems be able
to generate standardized clinical documents, Stage 2 requires that they be able to
transport clinical information from one system to another.
Stage 3 rules were announced in October 2015, making significant changes
intended to ease the reporting burden on all providers, support health information
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exchange, and improve patient outcomes. One important change is a shift in focus so that
health IT becomes a tool for care improvement, not an end in itself.
While each stage of Meaningful Use has sent ripples of change across the EHR
landscape in terms of functions and capabilities, each stage has also engendered evolution
in the very definition of an EHR. While Meaningful Use is not yet complete, it is not too
early to assess how it is already shaping the field. Setting common functional
requirements for EHRs and incentives for users to take advantage of those functions, the
Meaningful Use program has imposed a degree of coordination on healthcare that the
fragmentation of the industry has prevented up until now. Meaningful Use can go only so
far, however, as it is not robust enough to change larger and deeper trends in the industry
that are driving business arrangements and revenue models.
Meaningful Use has certainly been successful in creating a common floor of
capability across vendors’ systems, which has inalterably shaped the EHR industry. It has
also had a profound impact on the widespread adoption and use of EHR systems in
hospitals and physician practice.
Vendors have yet to reach plug-and-play capability with EHR systems, however,
and it is highly unlikely that Meaningful Use will have enough influence or enough time
to instill such capability in the market.
Problem Statement
There has been little research on the overall effectiveness of advanced EHRs on
medication errors in an inpatient setting. Various studies have attempted to show the
value of various aspects of technology on patient care, but no comprehensive research
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had been conducted to evaluate the relationship between advanced EHR use and
medication errors among US hospitals. This study has sought to understand the
relationship between advanced EHR use and medication errors in US hospitals
participating in HIMSS Analytics, a global, cause-based, not-for-profit organization
promoting better health through information technology (IT).
Research Question
What is the relationship between advanced EHRs use and medication errors rates
in HIMSS Analytics participating US hospitals?
Hypothesis
Hypothesis: Hospitals with advanced EHRs have lower rates of medication errors
compared to hospitals without advanced EHRs.
EHR Adoption Model
EHRs in our sample was grouped by stage of use, a model previously used by
Kazley (2014), based on individual application reported to be in use by the hospitals The
EHR usage level was classified into four stages based on various components of an EHR
reported to be in use at the time of reporting. These measures were grouped into
categories to measure the level EHR functionality of each hospital in its EHR journey
(see Table 1). This allowed us to measure the effects on medication error rates for each
hospital as the hospital adopts additional components of an EHR. The categories we used
are Stage 0 (no EHR applications installed), Stage 1 (EHR with ancillary services
including a clinical data repository, pharmacy, laboratory, and radiology information
systems), Stage 2 (Stage 1 plus EHR with nursing workflow including electronic nursing
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documentation and medication administration records), and Stage 3 (EHR with Stage 1
and 2 components, plus CPOE and clinical decision support). A hospital with Stage 3
EHR has reported successful implementation all of all Stage 1 and Stage 2 applications
plus CPOE and CDS. Teufel et al. (2012) point out that many of the functions present in
advanced Stage 3 would be considered minimal functions required to meet Meaningful
Use objectives. Since Stage 3 consists of more advanced automated features, Stage 3
hospitals should possess enhanced capabilities to handle the demands of providing high
quality care, which in turn will affect the patient safety capabilities of those hospitals.
Sample
The sample size was a 20% random sample of patients from hospitals using the
combined 2009 data from the National Inpatient Sample (NIS), HIMSS and AHA
datasets. The patients in our sample were grouped by stage of use of EHR at their
associated hospitals, a model previously used by Kazley (2014), based on individual
application reported to be in use by these hospitals in our sample.
Definitions
Key definitions in this research study are:
1. ADE: Adverse Drug Events
2. Advanced EHR: Advanced EHR will be classified as a hospital that has met
Stage 3 criteria for EHR adoption and use.
3. ARRA: The American Reinvestment & Recovery Act.
4. CDS: Clinical Decision Support
5. CPOE: Computerized Provider Order Entry
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6. HITECH: The Health Information Technology for Economic and Clinical
Health Act.
7. ME: Medication Error

CHAPTER 2
REVIEW OF THE LITERATURE
A comprehensive review of the available literature was conducted on previous
studies whose topics directly related to the research topic. Studies that focused on the
technology in healthcare were reviewed for their impact on the quality and safety of
healthcare. We concluded our literature review by reviewing studies relating to
meaningful use and EHR adoption to understand prior work and how it will impact this
study.
Patient Safety (Medication Errors)
Approximately one quarter of all adverse events that occur in hospitals are
adverse drug events or medication-related errors (Covell & Ritchie, 2009). Although
healthcare providers have ethical and professional obligations to disclose adverse events,
medication errors continue to be underreported. Consequently, little is known about the
types of medication errors that are not reported.
In To Err is Human, a 2002 study published by the Institute of Medicine (IOM),
Kohn et al. (2000) estimate that as many as 98,000 people die per year from medical
errors that occur in hospitals. Shojania et al. (2001) reviewed previously published
studies to understand existing evidence on practices relevant to improving patient safety.
They concluded that practices with the strongest supporting evidence are generally
clinical interventions that decrease the risks associated with hospitalization, critical care,
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or surgery. They also found that many patient safety practices drawn primarily from
nonmedical fields (e.g., use of simulators, bar coding, computerized physician order
entry, and crew resource management) deserve additional research to illuminate their
value in the health care environment.
Varkey & Bisping (2007) conducted a prospective trial on 104 primary care
patients at the Mayo Clinic to investigate how to improve medication reconciliation and
increase patient safety. Patients in Phase I received standard care. Patients in Phase II
received the intervention reconciliation process, which consisted of (1) mailing letters
before appointments to remind patients to bring medication bottles or updated medication
lists to their visits, (2) verifying medications, and (3) correcting the medication list in the
electronic medical record by the patient, and academic detailing and weekly audit and
feedback of performance. They found that interventions resulted in an 89% decrease in
prescription medication errors in Phase I and a 66% decrease in Phase II. Decreases in
errors from 98% of the visits in Phase I to a decrease of 84% of the visits in Phase II were
documented. When all medications were considered, a 98% decrease in medication errors
was documented in Phase I, as well as an 84% decrease in Phase II. The average number
of discrepancies per patient decreased by more than 50%, from 5.24 in Phase I to 2.46 in
Phase II.
To reduce the occurrence of medication-related errors, the Institute of Medicine
(IOM) recommends implementing health information technologies in conjunction with
other process improvements programs such as clear communication of drug information
between the provider and patient, a team-based approach that demands the attention of
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everyone involved, and encouraging the accrediting agencies to require training in
medication management practices (Aspden, 2006).
Healthcare Information Technology.
Computerized Provider Order Entry (CPOE) are electronic orders for medication,
laboratory and radiology services placed by a licensed healthcare professional into the
Electronic Health Record (EHR) per state, local and professional guidelines. In using
CPOE for medications, orders are incorporated with patient information, such as other
prescriptions and lab results, which can be automatically checked for potential errors or
problems. This real-time crosscheck improves optimal drug selection and reduces errors
at the time of ordering, a safer and more effective way to order medications than using
prescription pads or paper forms. Researchers found that 90 percent of all providers felt
that the VA electronic prescribing system, including its order check, improved
prescribing safety to some degree (Spina et al., 2011). It reduces the chance of selecting
medications for which the patient has a known allergy, or drugs that are off-formulary for
their health plan. Additionally, the medication information is updated in the patient’s
medical record and easily available for follow-up visits. Birkmeyer (2004) estimates that
universal implementation of CPOE would avert approximately 567,000 serious
medication errors each year in the United States.
While not all adverse events in healthcare are preventable, IOM concluded that
many could be avoided through better professional practices, more effective teamwork,
and new technology (Berkowitz, 2012). When implemented together, CPOE systems and
CDS can improve medication safety and quality of care and reduce costs of care
(Kaushal, 2003). The CPOE system employed a CDS element to provide clinicians with
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access to evidence-based guidelines, prompts, and alerts at the bedside. CPOE should not
be pursued in isolation from other technologies. Simply entering orders in a system
without providing clinical decision support during the order-entry process may have
limited benefit. In order to optimize impact on quality, safety, and efficiency, CPOE
should be an integrated component of the EHR system. They can also improve
compliance with provider guidelines, as well as the efficiency of hospital workflow
(Dexter, 2001). Most evidence demonstrating the value of CPOE comes from research in
hospital settings. CPOE and decision support systems (DSS) can reduce certain types of
error (Handler et al., 2004).
The results from a case study conducted at the University of Maryland in 2006 on
continuous medication infusion in a pediatric ICU showed the benefit of using CPOE
versus handwritten orders. The results indicated that a total of 234 orders were generated
using each method by 26 physicians ordering nine drips each. Orders placed using CPOE
required significantly less time (5.5 minutes + 2 minutes) as compared to the handwritten
method (26 minutes + 8 minutes). In addition, use of CPOE resulted in significantly
fewer errors: 10 of 243 drip orders (4.3%), compared to the handwritten method, where
170 of 243 drip orders (73%) contained one or more errors. Among the handwritten
errors, 25% were judged to be ‘high-risk’ with the potential for serious adverse effects
(Vaidya, 2006).
In a 2012 study, Dow et al. studied the impact of implementing CPOE on three
elements of medication use system performance: inpatient medication override dispense
rates from automated dispensing cabinets (ADCs), medication first-dose turnaround time
(TAT), and pharmacists’ perceptions of the medication orders management process.
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Their results support the positive effects of an advanced EHR on patient safety, indicating
that after the implementation of CPOE, the relative number of medication override
dispenses decreased by 58%. The mean time from order entry to order verification
improved by 76%, and the mean TAT for intravenous antibiotics improved by 31%.
Pharmacists’ overall satisfaction with the medication orders management process
improved by 23%. Dow et al. concluded that the implementation of CPOE resulted in
improvement in each of the three medication use system elements assessed.
A cross sectional nationwide study conducted with Veteran Administration (VA)
physicians on the perceptions of and experiences with order entry and order checks (drug
alerts) in an electronic prescribing system may help improve medication safety
technology. This study also shows systems using an advanced EHR can have a positive
impact on patient safety. Researchers found that 90% of all providers felt that the VA
electronic prescribing system, including its order check, improved prescribing safety to
some degree. A significant number (88%) of physicians who encountered serious allergic
or adverse drug reactions reported either notifying a pharmacist or entering the
information in the allergies/adverse reactions field, and 48% of providers described
critical drug-drug interaction alerts as very useful (Spina et al., 2011).
Wolfstadt et al. (2008) conducted a cross-sectional retrospective study on the
impact of CPOE with CDS on adverse drug event. The Wolfstadt study is significant to
this study in that of the nine studies that were evaluated in a hospital setting (One study
was done on an ambulatory care setting.), only three were conducted with hospitals with
COPE with CDS implemented house-wide. The Wolfstadt review only included three
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studies that used commercially sold systems, whereas seven studies used in-house
designed systems.
Evans et al. (1994) evaluated the prevention of ADEs with a computer alert
program that provided alerts of drug allergies at the time of drug ordering. The study used
a quasi-experimental pre/post design and found a significant reduction in the rate of
ADEs due to allergic reactions from 56 in the one-year baseline period to 8 and 18 during
two subsequent one-year study periods that incorporated CPOE with CDS (P < .002).
There were no ADEs in years two and three of the study involving patients whose drug
allergies were known and displayed, compared with 13 in the first year, when known
drug allergies were not displayed. Severe ADEs were significantly reduced from 41 in the
first study period to 12 and 15 during the two CPOE implementation periods (P < .001)
Bates et al. (1998) assessed the effectiveness of CPOE with CDS for reducing
preventable ADEs and demonstrated a reduction in the rates of both total ADEs and
preventable ADEs per 1,000 patient-days. The trend in total ADEs non-significantly fell
from 14.7 to 9.6 between the baseline and the third study period (P = .09), and the trend
in preventable ADEs significantly decreased from 2.9 in the baseline period to 1.1 in the
third study period (P = .05). The investigators reported a non-significant reduction of
17% in preventable ADEs during the intervention period (P = .37). This is significant for
our study, which will focus on preventable ADEs, in that an advanced EHR that includes
CPOE with CDS may have a greater impact on preventable ADEs such as medication
errors than one without it.
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In 2011 Zlabek et al. studied the early cost and safety benefits of an inpatient
EHR, in an inpatient setting. The study was conducted at Gundersen Lutheran Medical
Center, a community-based tertiary referral center and teaching hospital with 325
licensed beds and a Level 2 trauma center. During this retrospective longitudinal study,
data were collected for the period one year before EHR (pre-EHR) and one year postEHR implementation. Measures of cost of care, safety, and quality for which data were
readily available pre-EHR and post-EHR were selected and captured for all hospitalized
patients. Their results are as follows: Medication errors per 1000 hospital days decreased
from 17.9 to 15.4 (14.0%; p < 0.030), while near misses per 1000 hospital days increased
from 9.0 to 12.5 (38.9%; p < 0.037), and the percentage of medication events that were
medication errors decreased from 66.5% to 55.2% (p < 0.007).
Jayawardena (2007) conducted a retrospective study at a Brooklyn, NY hospital
to evaluate the efficacy of a CPOE system with the help of ancillary support in
minimizing prescription errors. They categorized the errors as inappropriate dosage
adjustment for creatinine clearance, duplication, incorrect orders, allergy verification, and
incomplete orders. The pharmacists identified the type of error, the severity of error, the
class of drug involved, and the department that made the error. A total of 466,311
prescriptions were entered during the period of one year, and 3513 errors were identified
during this period (7.53 errors per 1000 prescriptions). More than half of these errors
were made by the internal medicine specialty. In this study, 50% of the errors were
severe errors (overdosing medications with narrow therapeutic index or over-riding
allergies), 46% were moderate errors (overdosing, wrong dosing, duplicate orders, or
prescribing multiple antibiotics), and 4% were not harmful errors (wrong dosing or
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incomplete orders). The errors were also categorized according to the class of medication.
Errors in antibiotic prescription accounted for 54% of all errors. The pharmacist detected
all of these prescription errors as the prescriptions were reviewed in the CPOE system.
Jayawardena (2007) noted that prescription errors are common and found that the CPOE
system can prevent and alert the prescriber and pharmacist to dosage errors and allergies.
Involvement of the pharmacist in reviewing the prescription and alerting the physician
has minimized prescription errors to a great degree in this hospital setting (Jayawardena,
2007).
Studies have shown EHR implementations, especially CPOE, have a positive
correlation to the reduction of medication errors (Birkmeyer, 2004). The safe use of
medications is an important area of concern within health care. On its own, CPOE has an
impact on safety by ensuring that orders are legible, yet the value of this functionality is
increased by adding clinical decision support (CDS) systems (Kuperman, 2003). CDS is a
technology that provides clinicians with real-time feedback about a wide-range of
diagnostic and treatment-related information as they are entering electronic orders. By
running electronic rules in the background, decision support can check for a variety of
potential errors. Examples include drug interactions, patient allergies to prescribed
medications, medication contraindications, and renal- and weight-based dosing. An
advanced EHR with features such as CPOE with electronic prescribing, drug interaction
alerts, and information sharing among providers via exchanges can lead to a reduction in
adverse events. Leapfrog also estimates that universal implementation of CPOE would
avert approximately 567,000 serious medication errors each year in the United States
(Birkmeyer, 2004).
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Meaningful Use and EHR Adoption
The Electronic Health Record (EHR) adoption rate has increased significantly
over the past few years. 78 percent of office-based physicians report that they have
adopted some type of EHR system. About half of all physicians (48 percent) had an EHR
system with advanced functionalities in 2013, a doubling of the adoption rate in 2009,
and about 59 percent of hospitals had adopted an EHR system with certain advanced
functionalities in 2013, quadrupling the percentage for 2010 (HHS Press, 2014).
To attain the full effect of an advanced EHR, adoption is critical in both hospital
and physician practice setting. President Obama, following in his predecessor’s footsteps,
first declared the goal of near universal EHR use by 2014. In the early stages of the EHR
incentive program, approximately ten percent of hospitals and 20 percent of physicians
were using these systems, and even fewer could meet the preliminary definition of
meaningful use. Adoption of EHRs has been increasing at about three percent to six
percent per year (Jha, 2010), and the widespread use of EHRs in the United States is
inevitable. EHRs will improve caregivers’ decisions and patients’ outcomes (Blumenthal
& Tavenner, 2010). There is wide consensus regarding the potential of health information
technology, especially the EHR, to improve the quality and efficiency of clinical care and
to help the nation overcome the fragmented nature of its health-care system (Burke,
2010).
The adoption of interoperable EHR systems could produce efficiency and safety
savings of between $142 billion and $371 billion (Hillestad et al., 2005). In 2011 Jha et
al. studied their adoption in US hospitals and assessed their readiness for Meaningful
Use. The researchers in that study used data from an American Hospital Association
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survey conducted in 2010 to measure the percentages of applicable hospitals that have
adopted basic and comprehensive EHRs. Of the 2902 hospitals reviewed, more than 15
percent had adopted at least a “basic” EHR, representing nearly 75 percent growth since
2008 (Jha et al., 2011). Recent numbers released by CMS on healthit.gov suggest the
EHR adoption rates continue to rise as the Meaningful Use incentives take effect.
Adoption of EHR systems by non-federal acute care hospitals has steadily increased since
HITECH. In 2013, nearly 59 percent non-federal acute care hospitals had adopted at least
a basic EHR system with clinician notes. This represents a 34 percent increase from the
previous year and a more than five-fold increase in EHR adoption since 2008. In
addition, in 2013 a vast majority of acute care hospitals (93 percent) possessed EHR
technology certified as meeting federal requirements for Meaningful Use, this is a 29
percent increase from 2011. Hospital adoption of a Basic EHR without clinician notes has
declined marginally, while the systems with more advanced functionality have increased
significantly (Charles et al., 2014).
In a 2014 study, Diana et al. studied the factors identified with hospitals achieving
Meaningful Use criteria, using data from the 2011 American Hospital Association
Annual Survey, including the Information Technology Supplement, the Centers for
Medicare & Medicaid Services report of hospitals receiving meaningful use payments,
and the Health Resources and Services Administration's Area Resource File. They found
that 38 percent of eligible hospitals achieved Meaningful Use incentive thresholds by the
end of 2012. The study identified characteristics associated with organizations that
received incentive payments for having EHR in place in 2010 as a larger number of beds,
a single health information technology vendor, Joint Commission accreditation, for-profit
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status, Medicare share of inpatient days in the middle two quartiles, eligibility for
Medicaid incentives, and a location in the Middle Atlantic or South Atlantic census
region. The characteristics associated with not receiving incentive payments were
membership in a hospital system and being located in the Mountain or Pacific census
region. Diana et al. (2014) concluded that little evidence suggests that the HITECH
incentive program has enticed hospitals without an EHR system to adopt Meaningful Use
criteria. Policy makers should consider modifying the incentive program to accelerate the
adoption of and meaningful use in hospitals without EHRs.
Between 2008 and 2013, the number of hospitals with a Meaningful Use
compliant EHR doubled. There was a dramatic increase in the number of hospitals that
deployed CPOE and advanced clinical decision support (Gur-Arie, 2013).
Summary
A number of studies have shown that patient safety is of great concern to the
entire healthcare community, especially to patients. Covell & Ritchie (2009) concluded
that even though healthcare providers have ethical and professional obligations to
disclose adverse events, medication errors continue to be underreported. Consequently,
little is known about the types of medication errors that are not reported. Shojania et al.
(2001) found that many patient safety practices drawn primarily from nonmedical fields
(e.g., use of simulators, bar coding, computerized physician order entry, crew resource
management) deserve additional research to illuminate their value in the health care
environment. Varkey & Bisping (2007) found that interventions resulted in a decrease in
prescription medication errors significantly.
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In our review, healthcare information technology is shown to play a significant
role in the delivery of care, and a number of studies show a positive correlation between
healthcare information technology and improvement in the quality of care. Spina et al.
found that 90 percent of all providers felt that the VA’s electronic prescribing system,
including its order check, improved prescribing safety to some degree. CPOE with CDS
were shown to improve patient safety, according to Kurshal et al. (2006). More evidence
was offered by Dexter et al. that CPOE can also improve compliance with provider
guidelines, as well as the efficiency of hospital workflows. In their 2004 study, Handler
et al. suggest that CPOE and decision support systems (DSS) can reduce certain types of
errors, and Birkmeyer (2004) also concluded that CPOEs have a positive correlation to
the reduction of medication errors.
Studies also revealed that although the level of EHR adoption has increased, the
true impact of Meaningful Use is still to be determined. In 2010 Jha et al. found that EHR
adoption had increased to about 75 percent since 2008. Charles et al. (2014) show that the
number of EHRs with less advance features has declined marginally, while the number of
systems with more advance functionality has increased significantly. In a related study,
Diana et al. (2014) found that 38 percent of eligible hospitals had achieved Meaningful
Use incentive thresholds by the end of 2012. A number of studies were reviewed that
point to an increase in EHR adoption, but few or none showing the true impact of the
Meaningful Use incentives. That may come in time as systems mature and data is
collected on these newly implemented features.
Overall, the review of the available literature did shine a light on the importance
of patient safety practices and shows the impact of various parts of an EHR on patient
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safety and quality, but nothing significant relating to how advanced EHRs are impacting
medication errors. Our study attempts to fill this void and add to the knowledge base in
the area of patient safety.

CHAPTER 3
METHODOLOGY

Study Objective
There had been little research on the relationship between advanced EHRs and
medication errors rates in inpatient settings, using the HIMSS Analytics participating
hospitals as the sample population. Various studies had attempted to show the value of
various aspects of technology on patient care, yet no comprehensive research had been
conducted to evaluate the relationship between advanced EHRs and medication errors in
hospitals. This study is important because the EHR adoption rate has increased
significantly over the past few years, and to know the relationship between advance
EHRs and medication error rates can contribute to development of strategies that can
significantly affect quality of care. In this study, we analyzed HIMSS Analytics, AHA,
and NIS data to evaluate the impact of using advanced EHRs on adverse events in
healthcare, specifically comparing medication errors rates between hospitals using
advanced EHRs (Stage 3) and hospitals not using an advanced EHR. For the purposes of
this study, an advanced EHR necessarily included Computerized Provider Order Entry
(CPOE) and Clinical Decision Support (CDS), which corresponds to Stage 3 EHR
adoption.
Study Design
We conducted a retrospective, cross sectional patient-level study using the data
from HIMSS Analytics for each hospital’s advanced EHR adoption scores, AHA
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datasets, and the NIS data for the medication error rates. We analyzed the data to
determine to what extent medication errors are affected by advance EHRs. We identified
the independent variable as advanced EHR usage, and its effects on medication error
rates were measured.
Specification of Variables
In this study, the independent variable was advanced (Stage 3) EHR usage. The
EHR usage level was classified into four stages based on various components of an EHR
reported to be in use at the time of reporting. These measures were grouped into
categories to measure the level EHR functionality of each hospital in its EHR journey
(see Table 1). This was appropriate for our study in that it allowed us to measure the
effects on medication error rates for each hospital as the hospital adopts additional
components of an EHR. The categories we used are Stage 0 (no EHR applications
installed), Stage 1 (EHR with ancillary services including a clinical data repository,
pharmacy, laboratory, and radiology information systems), Stage 2 (Stage 1 plus EHR
with nursing workflow including electronic nursing documentation and medication
administration records), and Stage 3 (EHR with Stage 1 and 2 components, plus CPOE
and clinical decision support). A hospital with Stage 3 EHR reported successful
implementation all of all Stage 1 and Stage 2 applications plus CPOE and CDS. Teufel et
al. (2012) point out that many of the functions present in advanced Stage 3 would be
considered minimal functions required to meet Meaningful Use objectives. Since Stage 3
consists of more advanced automated features, we expected Stage 3 hospitals to possess
enhance capabilities to handle the demands of providing high quality care, which in turn
affects the patient safety capabilities of those hospitals.
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The dependent variable in this study was the number of medication errors found
at participating hospitals. The results were compared to a control group of hospitals
without advanced EHRs that were in Stages 0, 1, and 2 of EHR classification. The control
group for non-advanced EHR represented EHRs without CPOE of CDS. We tested
whether the experimental treatment/condition (advanced EHR) is associated with fewer
medication errors, and whether there is sufficient evidence to support the claim that it is.
We controlled for several hospital level variables: teaching status, urban location, bed
count, and geographical region. Given that the patient was the unit of analysis, we also
controlled for patient level variables: patient age, gender, race, private insurance
coverage, Medicare and Medicaid coverage, and whether the patient arrived as a transfer.
We also controlled for potential selection bias of advanced EHR use in hospitals and
potential differences in patient demographics, severity of errors, and hospital case mix
through the use of a propensity score stratification model. To calculate the propensity
score, a logistic regression analysis was performed to estimate the likelihood of each
patient being seen in a hospital with an advanced EHR (Table 5). Once calculated, the
propensity score variable was added to the multivariate model to control for potential
selection bias. Use of a propensity score approach can remove upward of 95% of bias
from estimates (Teufel et al., 2012).
Data Collection
We used secondary data from the HIMSS Analytics 2009 database for hospitals in
combination with The Healthcare Cost and Utilization Project’s (HCUP) National
Inpatient Sample (NIS) 2009 data for patient identifiers for medication errors and AHA
datasets. The HIMSS Analytics data were combined with demographic data from NIS to
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measure the impact of advanced EHR use and medication error rates. NIS is a family of
health care databases and related software products developed through a federal-stateindustry partnership and sponsored by the Agency for Healthcare Research and Quality
(AHRQ). NIS databases bring together the data collection efforts of state data
organizations, hospital associations, private data organizations, and the federal
government to create a national information resource of encounter-level health care data,
the National Inpatient Sample (NIS). NIS includes the largest collection of longitudinal
hospital care data in the United States, with all-payer, encounter-level information
beginning in 1988. These databases enable research on a broad range of health policy
issues, including cost and quality of health services, medical practice patterns, access to
health care programs, and outcomes of treatments at the national, state, and local market
levels (AHRQ.gov). The AHA database is based on an annual survey of US hospitals that
collects data about hospital characteristics and was used for control variables. The
International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM)
codes, assigned to virtually all inpatient discharges, provides a readily available
surveillance system capable of detecting an ADE (Table 2). The most frequently assigned
ICD-9-CM codes are diagnosis codes, external cause of injury codes (E-codes), and
procedure codes. In the case of an adverse drug event (ADE), a diagnosis code is used to
indicate the patient’s general diagnosis (e.g., 693.0, dermatitis due to drugs and
medicines taken internally), while the E-code indicates the drug class thought to be
responsible for these symptoms (e.g., E933.1, antineoplastic and immunosuppressive
drugs causing adverse effects in therapeutic use) (see Table 2).
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To determine the medication error rates, we employed the model used previously
by Hougland et al. in their 2006 study. They conducted a structured chart review and
abstraction to identify all Adverse Events and whether a flagged ICD-9-CM code
represented an Adverse Event. Adverse Event codes were grouped into six categories to
facilitate analysis: adverse drug events, surgical adverse events, misadventures,
infections, device events, and other adverse events. Our study focused on the Adverse
Drug Events (ADE) category to measure medication errors. Hougland et al. identified
416 ICD-9-CM codes representing ADEs (flagged ADE codes), which are represented in
Table 2. The Hougland study concluded that flagged ADE codes have a positive
predictive value of 25% for inpatient ADEs, and even though the flagged ADE codes
model is imperfect, it does provide an immediately available ADE surveillance system.
For the purposes of identifying medication errors, we measured ADE flagged
codes associated with clinical side effects, poisoning and adverse effects (see Table 2).
The poisoning codes for medication errors are used relatively infrequently. However, the
poisoning codes were much more likely to detect ADEs causing admission than those
ADEs that occurred in the hospital. Adverse effects codes are used more commonly than
the poisoning codes (Hougland et al., 2008).
Data Analysis
The number of medication errors was determined for each admission by adding
the number of ICD-9 to the number of E-codes corresponding to adverse drug effects (as
specified in previous studies) for each patient case. (Hougland et al., 2006) Medication
errors were categorized as clinical side effects, poisonings, and other adverse effects due
to various agents according to methods outlined by Hougland (2006).
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Overall means (continuous variables) and proportions (categorical variables) were
computed. Unadjusted analyses of patient and hospital-level characteristics were assessed
by advance EHR status using t-tests (continuous variables) and chi-squared tests
(categorical variables). Among those with at least one medication error, the types of
errors were compared descriptively by age, race, insurance, hospital’s number of beds,
and hospital region
The generalized linear models predicting the number medication errors and the
probability of an admission originating from hospital with an advanced electronic health
records (EHRs) (i.e. propensity model) were both controlled for the following patient
level variables: patient age, gender, race, All Patient Diagnosis Related Groups
(APDRGs) mortality and severity, insurance type (Medicaid, Medicare, private, other),
neonatal or maternal status, Diagnosis Related Group (DRG) case mix group, and
whether the patient arrived as a transfer. The following hospital-level variables were also
controlled for in each model: teaching status, hospital location (urban vs. rural),
hospital’s number of beds, and geographical region. Models were also weighted by
hospital.
A generalized linear model (binomial or logistic regression) was used to assess
whether the proportion of patient cases reporting at least one medication error differs
from hospitals with and without advanced EHRs. Generalized linear modeling was used
assess whether the number of medication errors differs between hospital with and without
advanced EHRs. Because the distribution of the number of medication errors contained
high prevalence of zeros, a zero-inflated Poisson model (rather than the usual Poisson
model) was used to model the total number of medication errors (see Table 4). Dependent
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variables following a Poisson distribution are expected to have a mean equal to the
variance. In cases of excessive zero counts, this condition is not satisfied, and overdispersion results. Over-dispersion can lead to an overestimate of standard errors, which
affects the ability to determine statistical significance of covariates within the model.
Furthermore, the underlying distribution is often a mixture of distributions including both
a distribution predicting zeros (binomial) and a distribution predicting counts (Poisson). It
has been demonstrated that the use of zero-inflated Poisson models can correct the
problem of over-dispersion (Lambert, 1992).
Two methods were used to control for selection bias. First, potential selection bias
of advanced EHR use in hospitals and Use of a propensity score approach has been
shown to remove upward of 95 percent of bias from estimates. (Tuefel, 2012). Potential
differences in patient demographics, case severity, and hospital case mix were controlled
by using propensity score stratification. The propensity score was generated by modeling
advanced EHR use by fitting a logistic regression model and estimating the probability of
advanced EHR for each patient case. These probabilities were stratified into quintiles,
and the stratified variable was added to the final model associating advanced EHR with
the outcomes of interest. Data were analyzed using SAS version 9.3, and the model was
run using the GENMOD procedure (SAS Institute Inc., 2002-2010) (see Table 6).
Second, potential selection bias due to case mix, patient and hospital
characteristics were examined using propensity score matching techniques. A five
percent random sample of the data was developed using propensity score matching based
on the nearest neighbor-matching greedy algorithm approach. The sample was limited to
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30,695 randomly selected observations from each group (hospitals with and without
advanced EHR.)

CHAPTER IV: FINDINGS

A 20 percent simple random sample of the combined 2009 NIS and HIMSS
datasets was utilized for this analysis. A total of 1,032,905 patient cases were selected. A
total of 301,289 (29.2%) patient cases originated from hospitals with an advanced EHR.
A total of 550 hospitals were included in the analysis, with 104 (18.9%) reporting use of
advanced EHR. The total number of medication errors per patient case ranged 0-11. The
total number of admissions with at least one medication error was 67,724 (6.6%), and the
average number of medication errors per patient case was 0.08 (SD = 0.35) overall,
which reflects the large number of patient cases reporting zero medication errors. The
average number of medication errors among patient cases with at least one medication
error was 1.27 (SD = 0.61), with an average of 1.27 (SD = 0.59) among admissions with
advanced EHR, and 1.27 (SD = 0.62) among those without advanced EHR, p < 0.0001.
Table 3 displays unadjusted differences in patient and hospital characteristics. All
differences were statistically significant. The majority of covariate differences were
small. Compared to patient cases from hospitals without advanced EHR, those with
advanced EHR included a lower proportion of medication errors (6.7% vs. 6.3%, p <
0.0001), were slightly younger in age, had a higher proportion of teaching hospitals and
hospitals in urban locations. Other differences are displayed in Table 3.
Additional unadjusted descriptive analyses of the subgroup of patient cases with
medication errors indicated that the majority of reported medication errors were adverse
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drug effects, while the least reported was poisonings as categorized by Hougland et al. in
their 2006 study. Adverse drug effects were highest among the oldest age group; while
poisonings were highest among the 18-44 year olds (see Table 2). The proportion of
patient cases reporting clinical side effects was similar among the adult age groups.
Among all patient cases with medication errors, White was the predominant
race/ethnicity represented, and the most prevalent payer/insurance was Medicare,
reflecting the demographic distribution of the patient population. Similarly, the majority
of medication errors were among the larger sized hospitals. The largest proportion of
patient cases reporting medication errors were from the South (31.6%), however, the
rates by geographical region were similar for each medication error category (see Table
3).
Results of the zero-inflated Poisson models revealed that advanced EHR was
positively associated with medication error, β = 0.0455 (p < 0.001), indicating that
admissions with advanced EHRs were five percent more likely to have zero medication
errors (OR = 1.047, 95% CI = 1.028-1.066) (see Table 4). No statistically significant
association between the number of advanced EHRs and medication errors was detected
from the Poisson portion of the regression model, β = 0.0095 (p = 0.2058) (see Table 5).
Variables associated with both presence of medication error and an increased number of
medication errors, included gender, race, risk severity, neonatal or maternal admission
status, teaching hospital designation, urban location, geographical region of hospital, case
mix, and propensity strata. Age was associated with a greater number of medication
errors than were risk mortality, hospital’s number of beds, and insurance, which were
each associated with at least one medication error.

34

Although the two-part model (zero-inflated Poisson) used to assess the association
between advanced EHR and number of medication errors included a model for assessing
the presence or absence of medication error, a second model was used to assess the
second objective (to determine whether the proportion of medication errors differs in
hospitals that do and do not use advanced EHRs). The remaining analyses focused on the
logistic regression model because (1) statistically significant association between the
presence of medication error and advanced EHR use were detected; (2) no statistically
significant association between total number of medication errors and advanced EHR use
were detected; and (3) the high proportion of zero medication errors per patient case
considerably lowers the overall average below 1, making the mean values uninformative,
indicating that the more valuable indicator is presence of medication error alone.
Controlling for propensity strata, patient and hospital characteristics in the multivariable
logistic regression model, the proportion of medication errors among hospitals without
advanced EHRs was 4.0%, while the proportion of medication errors among hospitals
with advanced EHRs was 3.9% (p < 0.0001) (see Table 4). Results from both the zeroinflated Poisson and the logistic regression models were controlled for propensity strata
(see Table 6).
Use of propensity score matching in the sensitivity analyses reduced the
heterogeneity in the advanced EHR and non-advanced EHR groups as evidenced by the
decrease in absolute standardized differences between covariates in the original dataset
and the matched sample (see Figure 1). Using the propensity matched sample, a slightly
higher proportion of medication errors was detected among the advanced EHR group
however, this association was no longer statistically significant (3.7% vs. 3.6%, p =
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0.3958). This indicates that the small statistically significant difference revealed in prior
analyses may have been due to selection bias.
Discussion
The most important finding in this study is that there was only a small difference
in the assumed direction to begin with, but it remained when using the propensity score
stratification although the association was no longer statistically significant when using
the matched sample. This is likely due first to the small prevalence of medication errors
overall and second, to the early stages implementation of advanced EHRs, as our data set
is from 2009.
Initial analyses provided weak evidence that advanced EHR could potentially
reduce medication error; however, sensitivity analyses indicated that this small difference
may have been due to bias. Nearly identical estimates for the average number of
medication errors and proportions of medication error in each group in dataset of this
large size further indicate no difference in medication error among patient cases with and
without advanced EHR. Additional analyses of the subgroup of patients with at least one
medical error did not reveal differences in the average number medication errors among
advanced and non-advanced EHR hospitals.
While this analysis was strengthened by its use of sensitivity analyses to control
selection bias, there are limitations. First, the data are cross-sectional, and at best only
provide weak evidence of any association between hospitals with and without advanced
EHR and medication error with any implication of a cause and effect relationship.
Second, data were collected in 2009, which represented a time of EHR uptake among
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hospitals. Thus, it is possible that even hospitals reporting advanced EHR may not have
fully or properly implemented all elements that could have had an effect on medication
errors. This uncaptured heterogeneity in advanced EHR hospitals could have weakened
the ability to detect differences in groups. Third, medication errors were identified using
ICD-9 codes consistent with medication errors and may not as sufficiently capture all
medication errors as more thorough review of records. Studies reporting more medication
errors at baseline have been associated with intervention study findings of greater
reductions in medication errors (Nuckols et al., 2014). Fourth, comparisons between
advanced EHR and all non-EHR, rather than solely focusing on hospitals without any
EHR could have produced greater differences. However, such an approach would not
have adequately measured specific differences in the stage of EHR, which was the focus
of this study. Fifth, some studies have indicated that the mere presence or absence of an
EHR may not affect medication error or adverse effects in general with other
characteristics that are key to implementation such as physician buy-in and ease of use
(Encinosa & Bae, 2013). Finally, this study did not focus on any particular patient group,
and it is possible that differences may be observed among subgroups that are not
detectable across all patient populations.
Although the result of little to no difference between rates of medication error in
advanced vs. non-advanced EHR hospitals differs from results of other studies,
descriptive analyses of characteristics of medication errors in general reflect that of
previous reports of healthcare utilization data. For example, a 2004 report of adverse
events found an overall prevalence of adverse drug events of about 3.1 (somewhat similar
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to the adjusted estimates of 4.0 and 3.9 reported in this study). Additionally, the
distributions of medication error categories by age were similar.
Additionally, the data used for our study are from 2009 and before the meaningful
use incentives took effect, which may also partially explain our results. The investment
from both the public and private sector increased significantly after 2009 to enhance the
functionality of EHRs. Consequently, the current data may tell a different story as, in
addition, these same hospitals also have more experience using EHR systems than they
did six years ago.
Technology alone will not solve the problem of medication errors in healthcare;
there must be comprehensive approach to the problem that includes the EHRs not
reliance on the EHR to solve the problem. Jha cites hyperbole around electronic health
records, along with real progress toward implementation: “But the potential is not going
to be realized unless those tools are really focused on improving patient safety. The tools
themselves won't automatically do it” (McCann, 2014).
Limitations
The data from HIMSS Analytics are mostly self-reported, causing some concerns
with the accuracy, but not significant enough concerns to affect the validity of this study.
Some other limitations are low reporting of adverse events, complexity of EHR
variability in configuration, low CPOE adoption rates and the lack of causation between
advanced EHR use and medication errors. Another limitation of our study is the age of
our data, which is from 2009 and is used because 2009 was the year HITECH was
enacted as part of the American Reinvestment and Recovery Act (ARRA) passed by
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Congress. This gives us a picture of the effects of using an advanced EHR before the
Meaningful Use incentives took effect. Also, we can only show association, not
causation, among our variables
A follow up study with current data is highly recommended to see how the results
will differ with all the technology and process enhancements since 2009, as hospitals are
now required to attest to a significant number of new advance features within an EHR
plus other meaningful use measures. It’s not acceptable anymore to limit CPOE or EHR
use to one unit.

Also, early adopters also have a lot more experience in using EHRs

which should reveal much more utility across the board.
.
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FIGURES AND TABLES
FIGURES
Figure 1
Standardized Mean Differences Plot
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TABLES
Table 1
EHR Adoption Model
Stage
Stage 0

Descriptor
No EHR applications installed

Stage 1

EHR with ancillary services including a clinical data repository,
pharmacy, laboratory, and radiology information systems

Stage 2

Stage 1 plus EHR with nursing workflow including electronic
nursing documentation and medication administration records
EHR with Stage 1 and 2 components, plus CPOE and clinical
decision support

Stage 3 (Advanced
EHR)
(Kazley, 2014)
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Table 2
International Classification of Diseases, 9th Revision, Clinical Modification Adverse
Drug Events Flag Code
ADE Type
Clinical side effects
Clinical side effects
Clinical side effects

Clinical side effects
Poisonings
Poisonings
Poisonings
Poisonings
Poisonings
Poisonings
Poisonings
Poisonings

Poisonings
Poisonings
Adverse effects
Adverse effects
Adverse effects
Adverse effects
Adverse effects
Adverse effects

Class
Drug psychoses
Dermatitis
Maternal causes of
perinatal
morbidity/mortality, drug
reactions and
intoxications specific to
newborn
Rash, spontaneous
ecchymoses
By antibiotics and other
antiinfectives
By hormones and synthetic
substitutes
By primarily systemic
agents
By agents primarily
affecting blood constituents
By analgesics, antipyretics,
antirheumatics
By anticonvulsant and antiParkinsonian drugs
By sedatives and hypnotics
By other central nervous
system depressants,
stimulants, anesthetics,
nervous system agents
By psychotropic agents
By other agents
Of antibiotics and other
antiinfectives
Of hormones and synthetic
substitutes
Of primarily systemic
agents
Of agents primarily
affecting blood constituents
Of analgesics, antipyretics,
antirheumatics
Of anticonvulsant and anti-

ICD9 Flag Code
292.0–292.9
692.3, 692.9, 693.0, 693.8, 693.9
760.72, 760.74, 763.5, 779.4

782.1, 782.7
960–961, E856–857
962, E858.0
963, E858.1
964, E858.2
965, E850
966, E855.0
967, E851–852
968, E855.1–855.9

969, E853–854
969, E853–854
E930–931
E932
E933
E934
E935
E936
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ADE Type
Adverse effects
Adverse effects

Adverse effects
Adverse effects

Adverse effects

Class
Parkinsonian drugs
Of sedatives and hypnotics
Of other central nervous
system depressants,
stimulants, anesthetics,
nervous system agents
Of psychotropic agents
Of agents primarily
affecting the cardiovascular
system
Of other drugs, biological,
medicinal substances in
therapeutic use

Source: Hougland et al., 2006

ICD9 Flag Code
E937
E938, E940–941

E939
E942

E943–E949
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Table 3
Hospital and Patient Characteristics by Advanced EHR Status
Total
(n=1032905)
Mean (SD)
n (%)
Age in years
Risk mortality
Risk severity

48.3 (27.9)
1.60 (0.88)
1.97 (0.91)

No Advanced
EHRs
(n=731616)
Mean (SD)
n (%)
49.4 (27.7)
1.62 (0.88)
1.95 (0.91)

Advanced EHRs
(n=301289)
Mean (SD)
n (%)

p-value

Adverse drug events
Medicaid
Medicare
Private insurance
Other ins/self pay/no
charge
Neonatal/maternal admit
Transfer into hospital
Race/Ethnicity
White
Black
Hispanic
Other/missing
Teaching hospital
Urban hospital
Small hospital
Medium hospital
Large hospital
Northeastern United
States
Midwestern United States
Western United States
Southern United States

67,724 (6.6)
215,441 (20.9)
380,804 (36.9)
343,188 (33.3)
91,350 (8.9)

48,772 (6.7)
149,105 (20.4)
281,521 (38.5)
237,420 (32.5)
62,332 (8.5)

18,952 (6.3)
66,338 (22.1)
99,283 (33.1)
105,768 (35.2)
29,018 (9.7)

<0.0001
<0.0001

235,592 (22.8)
56,766 (5.5)

162,799 (22.3)
35,497 (4.9)

72,793 (24.2)
21,269 (7.1)

<0.0001
<0.0001

591,032 (57.2)
117,404 (11.4)
124,379 (12.0)
200,086 (12.0)
504,828 (48.9)
930,479 (90.1)
116,715 (11.3)
248,545 (24.1)
667,645 (64.6)
281,526 (27.3)

433,788 (59.3)
76,097 (10.4)
90,275 (12.3)
131,452 (18.0)
310,797 (42.5)
639,567 (87.4)
93,943 (12.8)
170,981 (23.4)
466,692 (63.8)
166,609 (22.8)

157,244 (52.2)
41,307 (13.7)
34,104 (11.3)
68,634 (22.8)
194,031 (64.4)
290,912 (96.6)
22,772 (7.6)
77,564 (25.7)
200,953 (66.7)
114,917 (38.1)

<0.0001

133,327 (12.9)
295,064 (28.6)
322,988 (31.3)

72,746 (9.9)
22,9429 (31.4)
262,832 (35.9)

60,581 (20.1)
65,635 (21.8)
60,156 (20.0)

45.9 (28.0)
1.57 (0.87)
1.97 (0.91)

<0.0001
<0.0001
<0.0001

<0.0001
<0.0001
<0.0001

<0.0001
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Table 4
Zero-Inflated Poisson Parameter Estimates
Variable
Advanced EHRs
Age
Female
Race
Black
Hispanic
Other/unknown
White (ref)
Risk mortality
Risk severity
Neonatal or maternal admit
Teaching hospital
Hospital’s number of beds
Urban vs. Rural location
Insurance
Medicaid
Medicare
Other insurance/self-pay/no charge
Private
Geographic Region
Midwest
Northeast
South
West
Transferred into hospital
Case Mix
Propensity strata

Poisson
95% CI
-0.0052, 0.0242
-0.0105, -0.0096
0.0656, 0.0911

P
0.2058
<0.0001
<0.0001

Binomial (Probability of zero medication errors)
Estimate
95% CI
p
0.0045
0.0273, 0.0637
<0.0001
-0.0008
-0.0013, -0.0002
0.0051
-0.0434
-0.0593, -0.0275
<0.0001

-0.5211
-0.3660
-0.2649
Ref
-0.0059
0.0617
-0.6434
0.0871
-0.0049
0.1574

-0.5466, -0.4957
-0.3930, -0.3390
-0.2870, -0.2427

<0.0001
<0.0001
<0.0001

-0.3960
0.0840
-0.1527

-0.4304, -0.3617
0.0521, 0.1160,
-0.1803, -0.1250

<0.0001
<0.0001
<0.0001

-0.0164, 0.0047
0.0502, 0.0732
-0.6886, -0.5982
0.0677, 0.1065
-0.0161, 0.0062
0.1272, 0.1876

0.2744
<0.0001
<0.0001
<0.001
0.3841
<0.0001

-0.1992
-0.4464
1.4943
0.1579
0.0450
0.1052

-0.2128, -0.1855
-0.4603, -0.4325
1.4482, 1.5404
0.1336, 0.1822
0.0311, 0.0589
0.0672, 0.1432

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

0.0093
0.0217
0.0548
Ref

-0.0109, 0.0295
0.0038, 0.0397
0.0315, 0.0780

0.3669
0.0178
<0.0001

-0.1367
0.0690
-0.1392

-0.1610, -0.1124
-0.0912, -0.0467
-0.1671, -0.1112

<0.0001
<0.0001
<0.0001

0.0999
-0.0197
-0.0763
Ref
0.0399
-0.0138
-0.0695

0.0689, 0.1309
-0.0466, 0.0072
-0.0942, -0.0584

<0.001
0.1515
<0.0001

-0.1725
0.0760
-0.0178

-0.2114, -0.1336
0.0428, 0.1093
-0.0400, 0.0044

<0.0001
<0.0001
0.1157

0.0215, 0.0582
-0.0169, -0.0107
-0.0826, -0.0563

<0.0001
<0.0001
<0.0001

<0.0001
<0.0001
<0.0001

0.1199, 0.1666
0.0735, 0.0817
-0.0623, -0.0295

<0.0001
<0.0001
<0.0001

Estimate
0.0095
-0.0101
0.0784
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Table 5
Logistic Regression Parameter Estimates
Variable
Advanced EHRs
Age
Female
Race
Black
Hispanic
Other/unknown
White (ref)
Risk mortality
Risk severity
Neonatal or maternal admit
Teaching hospital
Hospital’s number of beds
Urban vs. Rural location
Insurance
Medicaid
Medicare
Other insurance/self-pay/no charge
Private
Geographic Region
Midwest
Northeast
South
West
Transferred into hospital
Case Mix
Propensity strata

Binomial (Probability of medication errors)
Estimate
95% CI
P
-0.0291
-0.0378, -0.0205
<0.0001
-0.0077
-0.0079, -0.0075
<0.0001
0.1081
0.1006, 0.1155
<0.0001
-0.1545
-0.3871
-0.0992
Ref
0.1368
0.4214
-1.9713
-0.0494
-0.0366
0.0590

-0.1669, -0.1422
0.4015, 0.3726
-0.1110, -0.0874

<0.0001
<0.0001
<0.001

0.1306, 0.1429
0.4150, 0.4278
-1.9919, -.1.9506
-0.0606, -0.0382
-0.0428, -0.0303
0.0424, 0.0757

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

0.1238
0.0720
0.1527
Ref

0.1116, 0.1360
0.0614, 0,0826
0.1386, 0.1668

<0.0001
<0.0001
<0.0001

0.3385
-0.0828
-0.0515
Ref
-0.0863
-0.0785
-0;.0257

0.2108, 0.2462
-0.0982, -0.0675
-0.0619, -0.0411

<0.0001
<0.0001
<0.0001

-0.0969, -0.0757
-0.0810, -0.0761
-0.0331, -0.0i83

<0.0001
<0.0001
<0.0001
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Table 6
Base Estimate Propensity Strata and Matched Sample Proportions of Medication Errors
Among Hospitals with and without Advanced EHR (Logistic Regression Model)
Base Estimate Propensity
Strata (n=1,032,905)
Advance EHR
No Advanced EHR
Difference

*p<0.05

0.039
0.040
0.01*

Base Estimate Propensity
Matched Sample
(n=61,390)
0.037
0.036
-0.01
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Table 7
NPSF Recommendations for Achieving a Total Systems Approach and Culture of Safety
1.

Ensure that leaders establish and sustain a safety culture.

2.

Create centralized and coordinated oversight of patient safety.

3.

Create a common set of metrics that reflect meaningful outcomes.

4.

Increase funding for research in patient safety and implementation science.

5.

Address safety across the entire care continuum.

6.

Support the health care workforce.

7.

Partner with patients and families for the safest care.

8.

Ensure that technology is safe and optimized to improve patient safety.

Source: NPSF (2015)

48

ARTICLE MANUSCRIPT
Advanced Electronic Health Records (EHR) and Their Impact on Adverse Events
and Medication Errors
Steven Goriah, DHA, PMP, CHCIO, FACHE©
Abby Kazley, PhD
Associate Professor, College of Health Professions, Medical University of South Carolina
Karen A. Wager, DBA
Professor and Associate Dean for Student Affairs, Medical University of South Carolina
Scott Stickles, DO
Radiologist, Mount Sinai Hospital of Queens
Correspondence regarding this article should be addressed to Steven Goriah, 28
Hazelton Circle, Briarcliff Manor NY 10510, 646-256-0923, sgoriah@gmail.com.

©Steven Goriah 2016 All rights reserved.

49

Abstract
Background
A review of the literature revealed the need for further analysis of the impact of
advanced electronic health record (EHR) use on medication error rates within US
hospitals.
Objective
To evaluate the effects of advanced electronic health record use on the medication
error rates in an inpatient setting.
Study Design
A retrospective cross-sectional patient level analysis using the combined 2009
data from the National Inpatient Sample (NIS), HIMSS, and AHA datasets was
conducted to study the relationship between advanced electronic health records use and
medication error rates.
Findings
A random sample of 1,032,905 patient cases was selected. A total of 301,289
(29.2%) patient cases originated from hospitals with an advanced EHR. A total of 550
hospitals were included in the analysis, with 104 (18.9%) reporting use of advanced
EHR. Compared to patient cases from hospitals without advanced EHR, those with
advanced EHR had a lower proportion of medication errors (6.7% vs. 6.3%, p < 0.0001).
The most important finding in this study is that there was only a small difference in the
assumed direction to begin with, but it remained when using the propensity score
stratification although the association was no longer statistically significant when using
the matched sample.
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Conclusions
While use of advanced EHRs has great potential for improving a variety of health
and safety matters in the hospital, it is possible that its current implementation has not
evolved enough to have an effect. Technology alone will not solve the problem, but it can
be a part of the solution. We must establish a total systems approach to problem of
patient safety where technology is part of the solution.

Keywords: CPOE: Computerized provider order entry (CPOE), clinical decision
support (CDS), adverse drug events (ADE), medication error (ME), advanced
electronic health record (EHR), The American Reinvestment & Recovery Act
(ARRA), Meaningful Use
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Advanced Electronic Health Records (EHR) and Their Impact on Medication
Errors
Introduction
Patient safety has emerged as a central measure of quality in today’s healthcare
environment that has far-reaching impact on various aspects in the continuum of care.
The practice of patient safety has been defined as those practices that reduce the risk of
adverse events related to exposure to medical care across a range of diagnoses or
conditions (Shojania et al., 2001). The Institute of Medicine (IOM) defines patient safety
as the prevention of harm to patients (Berkowitz et al., 2012) and places it under the
overarching umbrella of quality measures in healthcare (Kohn et al., 2000). Emphasis is
placed on the system of care delivery that (1) prevents errors, (2) learns from the errors
that do occur, and (3) is built on a culture of safety that involves health care
professionals, organizations, and patients (Aspden, 2004). The Agency for Healthcare
Research and Quality's (AHRQ) Patient Safety Network website expands upon the
definition of prevention of harm, describing it as freedom from accidental or preventable
injuries produced by medical care (AHRQ, 2007).
Background
A number of studies have shown that patient safety is of great concern to the
entire healthcare community, especially to patients. Covell & Ritchie (2009) concluded
that even though healthcare providers have ethical and professional obligations to
disclose adverse events, medication errors continue to be underreported. Consequently,
little is known about the types of medication errors that are not reported. Shojania et al.
(2001) found that many patient safety practices drawn primarily from nonmedical fields
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(e.g., use of simulators, bar coding, computerized physician order entry, crew resource
management) deserve additional research to illuminate their value in the health care
environment. Varkey & Bisping (2007) found that interventions resulted in a decrease in
prescription medication errors significantly.
In our review, healthcare information technology is shown to play a significant
role in the delivery of care, and a number of studies show a positive correlation between
healthcare information technology and improvement in the quality of care. Spina et al.
found that 90 percent of all providers felt that the VA’s electronic prescribing system,
including its order check, improved prescribing safety to some degree. CPOE with CDS
were shown to improve patient safety, according to Kurshal et al. (2006). More evidence
was offered by Dexter et al. (2001) that CPOE can also improve compliance with
provider guidelines, as well as the efficiency of hospital workflows. In their 2004 study,
Handler et al. suggest that CPOE and decision support systems (DSS) can reduce certain
types of errors, and Birkmeyer (2004) also concluded that CPOEs have a positive
correlation to the reduction of medication errors.
Studies also revealed that although the level of EHR adoption has increased, the
true impact of Meaningful Use is still to be determined. In 2010 Jha et al. found that EHR
adoption had increased to about 75 percent since 2008. Charles et al. (2014) show that the
number of EHRs with less advance features has declined marginally, while the number of
systems with more advance functionality has increased significantly. In a related study,
Diana et al. (2014) found that 38 percent of eligible hospitals had achieved Meaningful
Use incentive thresholds by the end of 2012. A number of studies were reviewed that
point to an increase in EHR adoption, but few or none showing the true impact of the
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Meaningful Use incentives. That may come in time as systems mature and data is
collected on these newly implemented features.
Overall, the review of the available literature did shine a light on the importance
of patient safety practices and shows the impact of various parts of an EHR on patient
safety and quality, but nothing significant relating to how advanced EHRs are impacting
medication errors. Our study will attempt to fill this void and add to the knowledge base
in the area of patient safety. IOM conducted a landmark study in 1999 on medical errors
and found that medical errors lead to the deaths of between 44,000 and 98,000 people in
US hospitals each year (JHITA, 2000). The Journal of the American Medical Association
gives a more conservative estimate and states that between 5,000 and 15,000 of those
deaths were preventable (Gillespie, 2002). One type of medical error is an adverse drug
event (ADE), which are a subset of those injuries associated with errors that occur during
the ordering, administering, dispensing, and monitoring of drugs. ADEs increase
morbidity, mortality and health care costs (Wolfstadt et al., 2008).
In addition to their impact on patient mortality, ADEs exact other significant
costs. They have been estimated to result in higher costs due to additional care
necessitated by the errors, lost income and household productivity, and disability of
between $17 billion and $29 billion per year in hospitals nationwide (JHITA, 2000). The
impact of medication errors is also felt when patients lose trust in the health care system
and when both patients and health professionals experience reduced satisfaction. Patients
who experience a long hospital stay or disability as a result of errors experience physical
and psychological discomfort. Health professionals pay with loss of morale and
frustration at not being able to provide the best care possible. Society bears the costs of
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errors as well, in terms of lost worker productivity, reduced school attendance by
children, and poorer population health (Kohn et al., 2000).
A number of factors contribute to medication errors. One of the most challenging
but preventable factors is the decentralized and fragmented nature of the healthcare
delivery system. When patients see multiple providers in different settings, none of whom
have access to complete information, it becomes easier for errors to occur (Kohn et al.,
2000).
Historically, most third-party purchasers of healthcare provided little financial
incentive for health care organizations and providers to improve safety and quality (Kohn
et al., 2000). Pay for Performance is changing the way Medicare pays for hospital care by
rewarding hospitals for delivering services of higher quality and higher value. The
program is an umbrella term for initiatives aimed at improving the quality, efficiency,
and overall value of health care. In some Pay for Performance models, payers consider
information technology critical to improving the coordination, quality, and efficiency of
care. In such a measure, payers might reward organizations for the use of an EHR to
order prescriptions for their patients, a process that can both lower costs and improve
quality by reducing medication errors (Cromwell et al., 2011).
Many patient safety practices that are tied to information technology, such as
simulators, bar coding, computerized physician order entries, and crew resource
management, which have been considered as possible strategies to avoid patient safety
errors and improve healthcare processes. Although not all adverse events in healthcare
are preventable, IOM concluded that many could be avoided through better professional
practices, more effective teamwork, and new technology (Berkowitz et al., 2012). EHRs
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that use computerized physician order entry (CPOE) with clinical decision support (CDS)
have been promoted as an effective strategy to prevent the development of a drug injury
defined as an adverse drug event (ADE) (Wolfstadt et al., 2008). CDS is a technology
that provides clinicians with real-time feedback about a wide range of diagnostic and
treatment-related information as they are entering electronic orders. By running
electronic rules in the background, decision support can check for a variety of potential
errors such as drug interactions, patient allergies to prescribed medications, medication
contraindications, and renal- and weight-based dosing. For a number of years,
organizations such as the Institute of Medicine and Leapfrog have been calling for
implementation of advanced EHRs, and CPOE in particular (Milstein et al., 2000).
The pace of change has greatly accelerated since the passage of the Health
Information Technology for Economic and Clinical Health Act (HITECH) which is part
of the American Reinvestment & Recovery Act (ARRA) of 2009. This is an effort to
transform healthcare delivery through widespread adoption and use of EHR technology.
Meaningful Use is an incentive program authored by the Centers for Medicare &
Medicaid Services (CMS) that provides eligible hospitals and professionals with financial
incentives to implement EHR systems and demonstrate “meaningful use” of certified
systems.
HITECH proposes the meaningful use of interoperable EHRs throughout the
health care delivery system as a critical national goal. The concept of meaningful use
rests on five pillars of health outcomes policy priorities, namely: (1) improving quality,
safety, efficiency, and reducing health disparities; (2) engaging patients and families in
their own healthcare; (3) improving care coordination; (4) improving population and
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public health; and (5) ensuring adequate privacy and security protection for personal
health information (CMS.gov).
By providing incentives to individual providers for using EHR systems in specific
ways, CMS has motivated a fragmented customer base to behave more like a single
customer with coherent demands. In effect, CMS, as a behind-the-scenes customer, is
driving standardization and the resulting economies of scale and scope in the EHR field
in the same way that large industry players have been able to standardize and draw value
from IT use in banking, retail merchandising, airlines, food services, and other sectors of
the economy. Understanding that markets are often slow to respond to customer demand,
and that EHR purchasers have limited ability to evaluate the quality of EHR vendor
products prior to purchase, HITECH also created federal certification of EHR products.
This certification gives a degree of assurance to providers and CMS about the quality of
EHR products they purchase (HealthIT.gov, 2016).
The Meaningful Use incentive program was established with three phases: Stage
1, Data Capture and Sharing; Stage 2, Advanced Clinical Processes; and Stage 3,
Improved Outcomes. Stage 1 of the Meaningful Use program focuses primarily on
promoting consistency of documentation in terms of what data should be captured
(content) and how it should be presented (structure). It does not address in detail how
data should be recorded (vocabulary) (HealthIT.gov, 2016). Stage 1 also links
documentation requirements with measurement and decision support requirements to
ensure that the data being captured are more than just a description of observations,
diagnoses, and treatments for future reference; clinicians now had the systems and the
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motivation to document in ways that would allow EHR systems to be tools for enhanced
decision-making (see Table 1).
In terms of interoperability of systems, Stage 1 focuses on promoting interorganization electronic transactions that were already gaining acceptance in the market,
such as e-prescribing, lab results delivery, and public health reporting. It also laid the
foundation for new types of transactions, specifically EHR-to-EHR transactions, by
requiring that systems be able to generate electronic record extracts that can be read by
other systems. The ability to electronically send, receive, and incorporate such extracts
from other EHR systems was left for more advanced stages.
Stage 2 Meaningful Use requires hospitals and health care providers to meet more
advanced requirements to qualify for incentives during this stage, and specifies what
criteria electronic health records must meet to achieve certification. Specific to Stage 2,
the capability to submit electronic data about immunizations is in the core set of criteria
for eligible professionals (EPs), as are the capability to submit electronic data for
immunizations, reportable laboratory results, and syndromic surveillance. In addition,
two new public health objectives for EPs have been added to the menu set, requiring the
capability to 1) identify and report cancer cases to a cancer registry and 2) identify and
report non-cancer cases to specialized registries.
Stage 2 further refines the notion of system-neutral records by taking EHR-toEHR interoperability further and requiring not just common structures (consolidated
clinical document architecture (CDA)) and common content (problems, labs,
medications, etc.), but use of specific vocabularies as well, such as SNOMED CT,
LOINC, and RxNORM, to enable cross-system understanding of clinical information
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from one organization to another. And while Stage 1 simply requires that systems be able
to generate standardized clinical documents, Stage 2 requires that they be able to
transport clinical information from one system to another.
Stage 3 rules were announced in October 2015, making significant changes
intended to ease the reporting burden on all providers, support health information
exchange, and improve patient outcomes. One important change is a shift in focus so that
health IT becomes a tool for care improvement, not an end in itself.
While each stage of Meaningful Use has sent ripples of change across the EHR
landscape in terms of functions and capabilities, each stage has also engendered evolution
in the very definition of an EHR. While Meaningful Use is not yet complete, it is not too
early to assess how it is already shaping the field. Setting common functional
requirements for EHRs and incentives for users to take advantage of those functions, the
Meaningful Use program has imposed a degree of coordination on healthcare that the
fragmentation of the industry has prevented up until now. Meaningful Use can go only so
far, however, as it is not robust enough to change larger and deeper trends in the industry
that are driving business arrangements and revenue models.
Meaningful Use has certainly been successful in creating a common floor of
capability across vendors’ systems, which has inalterably shaped the EHR industry. It has
also had a profound impact on the widespread adoption and use of EHR systems in
hospitals and physician practice. Vendors have yet to reach plug-and-play capability with
EHR systems, however, and it is highly unlikely that Meaningful Use will have enough
influence or enough time to instill such capability in the market.
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Study Purpose/Hypothesis
There has been little research on the overall effectiveness of advanced EHRs on
medication errors in an inpatient setting, using the HIMSS Analytics participating
hospitals as the sample population. Various studies have attempted to show the value of
various aspects of technology on patient care, but no comprehensive research had
conducted to evaluate the relationship between advanced EHR use and medication errors
among US hospitals. This study has sought to describe the relationship between advanced
EHR use and medication errors among US hospitals participating in a survey by HIMSS,
a global, cause-based, not-for-profit organization focused on better health through
information technology (IT). The research hypothesis of this study was that hospitals
with advanced EHRs have lower rates of medication errors compared to hospitals without
advanced EHRs.
Methods
Sample and Databases
The sample size was a 20% random sample of patients in the HIMSS Analytics
data 2009 that includes a broad canvassing of acute care hospitals, which are also in the
NIS and AHA datasets. The patients in our sample were grouped by stage of use of EHR,
a model previously used by Kazley (2014), based on individual application reported to be
in use by these hospitals in our sample.
Study Design
We conducted a retrospective, cross-sectional patient level study of the data from
HIMSS Analytics for each hospital’s advanced EHR adoption scores, AHA datasets, and
the NIS data for the medication error rates. We analyzed the data to determine to what
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extent medication errors are affected by advance EHR usage. We identified the
independent variable as advanced EHR usage, and its effects on medication error rates
were measured.
Specification of variables. In this study, the independent variable was advanced
(Stage 3) EHR usage. The EHR usage level was classified into four stages based on
various components of an EHR reported to be in use at the time of reporting (see Table
1). These measures were grouped into categories to measure the level EHR functionality
of each hospital in its EHR journey. This was appropriate for our study in that it allowed
us to measure the effects on medication error rates for each hospital as the hospital adopts
additional components of an EHR. The categories we used are Stage 0 (no EHR
applications installed), Stage 1 (EHR with ancillary services including a clinical data
repository, pharmacy, laboratory, and radiology information systems), Stage 2 (Stage 1
plus EHR with nursing workflow including electronic nursing documentation and
medication administration records), and Stage 3 (EHR with Stage 1 and 2 components,
plus CPOE and clinical decision support). A hospital with Stage 3 EHR reported
successful implementation all of all Stage 1 and Stage 2 applications plus CPOE and
CDS. Teufel et al. (2012) point out that many of the functions present in advanced Stage
3 would be considered minimal functions required to meet Meaningful Use Stage 1
objectives. Since Stage 3 consists of more advanced automated features, we expected
Stage 3 hospitals to possess enhance capabilities to handle the demands of providing high
quality care, which in turn affects the patient safety capabilities of those hospitals.
The dependent variable in this study was the number of medication errors found
at participating hospitals. The results were compared to a control group of hospitals
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without advanced EHRs that are in Stages 0, 1, and 2 of our EHR classification model.
The control group for non-advanced EHR represented EHRs without CPOE of CDS. We
tested whether the experimental treatment/condition (advanced EHR) is associated with
fewer medication errors, and whether there is sufficient evidence to support the claim that
it is. We controlled for several hospital level variables: teaching status, urban location,
bed count, and geographical region. Given that the patient was the unit of analysis, we
also controlled for patient level variables: patient age, gender, race, private insurance
coverage, Medicare and Medicaid coverage, and whether the patient arrived as a transfer.
We also controlled for potential selection bias of advanced EHR use in hospitals and
potential differences in patient demographics, severity of errors, and hospital case mix
through the use of a propensity score stratification model. To calculate the propensity
score, a logistic regression analysis was performed to estimate the likelihood of each
patient being seen in a hospital with an advanced EHR (see Table 5). Once calculated, the
propensity score variable was added to the multivariate model to control for potential
selection bias. Use of a propensity score approach can remove upward of 95% of bias
from estimates (Teufel et al., 2012).
Data collection. We used secondary data from the HIMSS Analytics 2009
database for hospitals in combination with the National Inpatient Sample (NIS) 2009 data
for patient identifiers for medication errors and AHA datasets. The HIMSS Analytics
data were combined with demographic data from NIS to measure the impact of advanced
EHR use and medication error rates. NIS is a family of health care databases and related
software products developed through a federal-state-industry partnership and sponsored
by the Agency for Healthcare Research and Quality (AHRQ). NIS databases bring
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together the data collection efforts of state data organizations, hospital associations,
private data organizations, and the federal government to create a national information
resource of encounter-level health care data, the National Inpatient Sample (NIS). NIS
includes the largest collection of longitudinal hospital care data in the United States, with
all-payer, encounter-level information beginning in 1988. These databases enable
research on a broad range of health policy issues, including cost and quality of health
services, medical practice patterns, access to health care programs, and outcomes of
treatments at the national, state, and local market levels (AHRQ.gov). The AHA database
is based on an annual survey of US hospitals that collects data about hospital
characteristics and was used for control variables.
The International Classification of Diseases, 9th Revision, Clinical Modification
(ICD-9-CM) codes, assigned to virtually all inpatient discharges, provides a readily
available surveillance system capable of detecting an ADE. The most frequently assigned
ICD-9-CM codes are diagnosis codes, external cause of injury codes (E-codes), and
procedure codes. In the case of an adverse drug event (ADE), a diagnosis code is used to
indicate the patient’s general diagnosis (e.g., 693.0, dermatitis due to drugs and
medicines taken internally), while the E-code indicates the drug class thought to be
responsible for these symptoms (e.g., E933.1, antineoplastic and immunosuppressive
drugs causing adverse effects in therapeutic use) (see Table 2).
To determine the medication error rates, we employed the model used previously
by Hougland et al. in their 2006 study. They conducted a structured chart review and
abstraction to identify all Adverse Events and whether a flagged ICD-9-CM code
represented an Adverse Event. Adverse Event codes were grouped into six categories to
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facilitate analysis: adverse drug events, surgical adverse events, misadventures,
infections, device events, and other adverse events. Our study focused on the Adverse
Drug Events (ADE) category to measure medication errors. Hougland et al. identified
416 ICD-9-CM codes representing ADEs (flagged ADE codes) which are represented in
Table 2. The Hougland study concluded that flagged ADE codes have a positive
predictive value of 25% for inpatient ADEs, and even though the flagged ADE codes
model is imperfect, it does provide an immediately available ADE surveillance system.
For the purposes of identifying medication errors, we measured ADE flagged
codes associated with clinical side effects, poisoning, and adverse effects (see Table 2).
The poisoning codes for medication errors are used relatively infrequently; however, the
poisoning codes were much more likely to detect ADEs causing admission than those
ADEs that occurred in the hospital. Adverse effects codes are used more commonly than
the poisoning codes, which are the adverse effect codes that denote adverse drug
reactions (Hougland et al., 2008).
Data Analysis
The number of medication errors was determined for each admission by adding
the number of ICD-9 and the number of E-codes corresponding to adverse drug effects
(as specified in previous studies) for each patient case. (Hougland et al., 2006)
Medication errors were categorized as clinical side effects, poisonings, and other adverse
effects due to various agents according to methods outlined by Hougland (2006).
Overall means (continuous variables) and proportions (categorical variables) were
computed. Unadjusted analyses of patient and hospital-level characteristics were assessed
by advance EHR status using t-tests (continuous variables) and chi-squared tests
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(categorical variables). Among those with at least one medication error, the types of
errors were compared descriptively by age, race, insurance, hospital’s number of beds,
and hospital region.
The generalized linear models predicting the number of medication errors and the
probability of an admission originating from hospital with an advanced electronic health
records (EHRs) (i.e. propensity model) were both controlled for the following patient
level variables: patient age, gender, race, All Patient Diagnosis Related Groups
(APDRGs) mortality and severity, insurance type (Medicaid, Medicare, private, other),
neonatal or maternal status, Diagnosis Related Group (DRG) case mix group, and
whether the patient arrived as a transfer. The following hospital-level variables were also
controlled for in each model: teaching status, hospital location (urban vs. rural),
hospital’s number of beds, and geographical region. Models were also weighted by
hospital.
A generalized linear model (binomial or logistic regression) was used to assess
whether the proportion of patient cases reporting at least one medication error differs
from hospitals with and without advanced EHRs. Generalized linear modeling was used
assess whether the number of medication errors differs between hospital with and without
advanced EHRs. Because the distribution of the number of medication errors contained
high prevalence of zeros, a zero-inflated Poisson model (rather than the usual Poisson
model) was used to model the total number of medication errors (see Table 4). Dependent
variables following a Poisson distribution are expected to have a mean equal to the
variance. In cases of excessive zero counts, this condition is not satisfied, and overdispersion results. Over-dispersion can lead to an overestimate of standard errors, which
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affects the ability to determine statistical significance of covariates within the model.
Furthermore, the underlying distribution is often a mixture of distributions including both
a distribution predicting zeros (binomial) and a distribution predicting counts (Poisson). It
has been demonstrated that the use of zero-inflated Poisson models can correct the
problem of over-dispersion (Lambert, 1992).
Two methods were used to control for selection bias. First, potential selection bias
of advanced EHR use in hospitals and potential differences in patient demographics, case
severity, and hospital case mix were controlled by using propensity score stratification
(see Table 6). The propensity score was generated by modeling advanced EHR use by
fitting a logistic regression model and estimating the probability of advanced EHR for
each patient case. These probabilities were stratified into quintiles, and the stratified
variable was added to the final model associating advanced EHR with the outcomes of
interest. Use of a propensity score approach has been shown to remove upward of 95% of
bias from estimates. (Tuefel, 2012). Data were analyzed using SAS version 9.3, and the
model was run using the GENMOD procedure (SAS Institute Inc., 2002-2010) (see Table
6).
Second, potential selection bias due to case mix, patient and hospital
characteristics were examined using propensity score matching techniques. A five
percent random sample of the data was developed using propensity score matching based
on the nearest neighbor-matching greedy algorithm approach. The sample was limited to
30,695 randomly selected observations from each group (hospitals with and without
advanced EHR.)
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Findings
A 20 percent simple random sample of the combined 2009 NIS and NIMMSS
datasets was utilized for this analysis. A total of 1,032,905 patient cases were selected. A
total of 301,289 (29.2%) patient cases originated from hospitals with an advanced EHR.
A total of 550 hospitals were included in the analysis, with 104 (18.9%) reporting use of
advanced EHR. The total number of medication errors per patient case ranged 0-11. The
total number of admissions with at least one medication error was 67,724 (6.6%), and the
average number of medication errors per patient case was 0.08 (SD = 0.35) overall,
which is reflective of the large number of patient cases reporting zero medication errors.
The average number of medication errors among patient cases with at least one
medication error was 1.27 (SD = 0.61), with an average of 1.27 (SD = 0.59) among
admissions with advanced EHR, and 1.27 (SD = 0.62) among those without an advanced
EHR, p < 0.0001.
Table 3 displays unadjusted differences in patient and hospital characteristics. All
differences were statistically significant. The majority of covariate differences were
small. Compared to patient cases from hospitals without advanced EHR, those with
advanced EHR included a lower proportion of medication errors (6.7% vs. 6.3%, p <
0.0001), were slightly younger in age, had a higher proportion of teaching hospitals and
hospitals in urban locations. Other differences are displayed in Table 3.
Additional unadjusted descriptive analyses of the subgroup of patient cases with
medication errors indicated that the majority of reported medication errors were adverse
drug effects, while the least reported was poisonings as categorized by Hougland et al. in
their 2006 study. Adverse drug effects were highest among the oldest age group, while
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poisonings were highest among the 18-44 year olds (see Table 2). The proportion of
patient cases reporting clinical side effects was similar among the adult age groups.
Among all patient cases with medication errors, White was the predominant
race/ethnicity represented, and the most prevalent payer/insurance was Medicare,
reflecting the distribution of the patient population. Similarly, the majority of medication
errors were among the larger sized hospitals. The largest proportion of patient cases
reporting medication errors were from the South (31.6%), however, the rates by
geographical region were similar for each medication error category (see Table 3).
Results of the zero-inflated Poisson models revealed that advanced EHR was
positively associated with medication error, β = 0.0455 (p < 0.001), indicating that
admissions with advanced EHRs were five percent more likely to have zero medication
errors (OR = 1.047, 95% CI = 1.028-1.066) (see Table 4). No statistically significant
association between the number of advanced EHRs and medication errors and was
detected from the Poisson portion of the regression model, β = 0.0095 (p = 0.2058).
Variables associated with both presence of medication error and an increased number of
medication errors, included gender, race, risk severity, neonatal or maternal admission
status, teaching hospital designation, urban location, geographical region of hospital, case
mix, and propensity strata. Age was associated with a greater number of medication
errors than were risk mortality, hospital’s number of beds, and insurance, which were
each associated with at least one medication error.
Although the two-part model (zero-inflated Poisson) used to assess the association
between advanced EHR and number of medication errors included a model for assessing
the presence or absence of medication error, a second model was used to assess the
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second objective (to determine whether the proportion of medication errors differs in
hospitals that do and do not use advanced EHRs). The remaining analyses focused on the
logistic regression model (see Table 5) because (1) statistically significant association
between number of medication errors and advance EHR use were detected; (2) no
statistically significant association between number of medication errors and advanced
EHR use were detected; and (3) the high proportion of zero medication errors per patient
case considerably lowers the overall average below 1, making the mean values
uninformative, indicating that the more valuable indicator is presence of medication error
alone. Controlling for propensity strata, patient and hospital characteristics in the
multivariable logistic regression model, the proportion of medication errors among
hospitals without advanced EHRs was 4.0%, while the proportion of medication errors
among hospitals with advanced EHRs was 3.9% (p < 0.0001) (see Table 4). Results from
both the zero-inflated Poisson and the logistic regression models were controlled for
propensity strata.
Use of propensity score matching in the sensitivity analyses reduced the
heterogeneity in the advanced EHR and non-advanced EHR groups as evidenced by the
decrease in absolute standardized differences between covariates in the original dataset
and the matched sample (Figure 1). Using the propensity matched sample, a slightly
higher proportion of medication errors was detected among the advanced EHR group;
however, this association was no longer statistically significant (3.7% vs. 3.6%, p =
0.3958). This indicates that the small statistically significant difference revealed in prior
analyses may have been due to selection bias (see Table 6).
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The most important finding in this study is that there was only a small difference
in the assumed direction to begin with, but it remained when using the propensity score
stratification even though the association was no longer statistically significant when
using the matched sample. This is likely due first to the small prevalence of medication
errors overall and second, to the early stages implementation of advanced EHRs, as our
data set is from 2009.
Discussion
The most important finding in this study is that there was only a small difference
in the assumed direction to begin with, but it remained when using the propensity score
stratification although the association was no longer statistically significant when using
the matched sample. This is likely due first to the small prevalence of medication errors
overall and second, to the early stages implementation of advanced EHRs, as our data set
is from 2009.
Initial analyses provided weak evidence that advanced EHR could potentially
reduce medication error; however, sensitivity analyses indicated that this small difference
may have been due to bias. Nearly identical estimates for the average number of
medication errors and proportions of medication error in each group in dataset of this
large size further indicate no difference in medication error among patient cases with and
without advanced EHR. Additional analyses of the subgroup of patients with at least one
medical error did not reveal differences in the average number medication errors among
advanced and non-advanced EHR hospitals.
While this analysis was strengthened by its use of sensitivity analyses to control
selection bias, there are limitations. First, the data are cross-sectional, and at best only
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provide weak evidence of an association between hospitals with and without advanced
EHR and medication error with any implication of a cause and effect relationship.
Second, data were collected in 2009, which represented a time of EHR uptake among
hospitals. Thus, it is possible that even hospitals reporting advanced EHR may not have
fully or properly implemented all elements that could have had an effect on medication
errors. This uncaptured heterogeneity in advanced EHR hospitals could have weakened
the ability to detect differences in groups. Third, medication errors were identified using
ICD-9 codes consistent with medication errors and may not as sufficiently capture all
medication errors as a more thorough review of records. Studies reporting more
medication errors at baseline have been associated with intervention study findings of
greater reductions in medication errors (Nuckols et al., 2014). Fourth, comparisons
between advanced EHR and all non-EHR, rather than solely focusing on hospitals
without any EHR could have produced greater differences. However, such an approach
would not have adequately measured specific differences in the stage of EHR, which was
the focus of this study. Fifth, some studies have indicated that the mere presence or
absence of an EHR may not affect medication error or adverse effects in general with
other characteristics that are key to implementation such as physician buy-in and ease of
use (Encinosa & Bae, 2013). Finally, this study did not focus on any particular patient
group, and it is possible that differences may be observed among subgroups that are not
detectable across all patient populations.
Although the result of little to no difference between rates of medication error in
advanced vs. non-advanced EHR hospitals differs from results of other studies,
descriptive analyses of characteristics of medication errors in general reflect that of

71

previous reports of healthcare utilization data. For example, a 2004 report of adverse
events found an overall prevalence of adverse drug events of about 3.1 (somewhat similar
to the adjusted estimates of 4.0 and 3.9 reported in this study). Additionally, the
distributions of medication error categories by age were similar.
Additionally, the data used for our study are from 2009 and before the meaningful
use incentives took effect, which may also partially explain our results. The investment
from both the public and private sector increased significantly after 2009 to enhance the
functionality of EHRs, so the current data may tell a different story.
Technology alone will not solve the problem of medication errors in healthcare;
there must be comprehensive approach to the problem that includes the EHRs not
reliance on the EHR to solve the problem. Jha cites hyperbole around electronic health
records, along with real progress toward implementation: “But the potential is not going
to be realized unless those tools are really focused on improving patient safety. The tools
themselves won't automatically do it” (McCann, 2014)
Limitations
The data from HIMSS Analytics are mostly self-reported, causing some concerns
with the accuracy, but not significant enough concerns to affect the validity of this study.
Some other limitations are low reporting of adverse events, complexity of EHR
variability in configuration, low CPOE adoption rates and the lack of causation between
advanced EHR use and medication errors. Another limitation of our study is the age of
our data, which is from 2009 and is used because 2009 was the year HITECH was
enacted as part of the American Reinvestment and Recovery Act (ARRA) passed by
Congress. This gives us a picture of the effects of using an advanced EHR before the
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Meaningful Use incentives took effect. Also, we can only show association, not
causation, among our variables. A follow-up study with current data is highly
recommended to see how the results will differ with all the technology and process
enhancements since 2009, as hospitals are now required to attest to a significant number
of new advance features within an EHR plus other meaningful use measures. It is not
acceptable anymore to limit CPOE or EHR use to one unit. Also, early adopters also
have a lot more experience in using EHRs which should reveal much more utility across
the board.
Conclusion
Although technology can be used a tool as part of the solution, it is not the
solution to the issues surrounding patient safety. For us to see a significant reduction in
the medical errors, we must establish a total systems approach to the problem, where
technology is only part of the solution. In early 2015, The National Patient Safety
Foundation (NPSF) assembled a group of industry experts to assentation the current state
of patient safety and they concluded in their final report that a total systems approach is
needed to address the problem. In a final report entitled Free From Harm- Accelerating
Patient Safety Improvements Fifteen years after to Err is Human, the panel provided eight
recommendations for achieving total patient safety (see Table 7). The leading
recommendation is to ensure that leaders establish and sustain a culture of safety;
technology was included as the Number 8 recommendation. If we are to make advances
in this area, this is the playbook that should be followed to establish total systems
approach to patient safety.
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TABLES

Table 1. EHR Adoption Model
Stage
Stage 0

Descriptor
No EHR applications installed

Stage 1

EHR with ancillary services including a clinical data repository,
pharmacy, laboratory, and radiology information systems

Stage 2

Stage 1 plus EHR with nursing workflow including electronic
nursing documentation and medication administration records
EHR with Stage 1 and 2 components, plus CPOE and clinical
decision support

Stage 3 (Advanced
EHR)
(Kazley, 2014)
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Table 2. International Classification of Diseases, 9th Revision, Clinical Modification
Adverse Drug Events Flag Code
ADE Type
Clinical side effects
Clinical side effects

Class
Drug psychoses
Dermatitis

Clinical side effects

Maternal causes of perinatal
morbidity/mortality, drug
reactions and
intoxications specific to
newborn
Rash, spontaneous
ecchymoses
By antibiotics and other
antiinfectives
By hormones and synthetic
substitutes
By primarily systemic
agents
By agents primarily
affecting blood constituents
By analgesics, antipyretics,
antirheumatics
By anticonvulsant and antiParkinsonian drugs
By sedatives and hypnotics
By other central nervous
system depressants,
stimulants, anesthetics,
nervous system agents
By psychotropic agents
By other agents
Of antibiotics and other
antiinfectives
Of hormones and synthetic
substitutes
Of primarily systemic
agents
Of agents primarily
affecting blood constituents
Of analgesics, antipyretics,
antirheumatics
Of anticonvulsant and antiParkinsonian drugs
Of sedatives and hypnotics

Clinical side effects
Poisonings
Poisonings
Poisonings
Poisonings
Poisonings
Poisonings
Poisonings
Poisonings

Poisonings
Poisonings
Adverse effects
Adverse effects
Adverse effects
Adverse effects
Adverse effects
Adverse effects
Adverse effects

ICD9 Flag Code
292.0–292.9
692.3, 692.9, 693.0, 693.8,
693.9

760.72, 760.74, 763.5, 779.4

782.1, 782.7
960–961, E856–857
962, E858.0
963, E858.1
964, E858.2
965, E850
966, E855.0
967, E851–852
968, E855.1–855.9
969, E853–854
969, E853–854
E930–931
E932
E933
E934
E935
E936
E937
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ADE Type
Adverse effects

Adverse effects
Adverse effects

Adverse effects

Class
Of other central nervous
system depressants,
stimulants, anesthetics,
nervous system agents
Of psychotropic agents
Of agents primarily
affecting the cardiovascular
system
Of other drugs, biological,
medicinal substances in
therapeutic use

Source: Hougland et al., (2006)

ICD9 Flag Code
E938, E940–941
E939
E942

E943–E949
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Table 3. Hospital and Patient Characteristics by Advanced EHR Status
Total
(n = 1032905)
Mean (SD)
n (%)
Age in years
Risk mortality
Risk severity

48.3 (27.9)
1.60 (0.88)
1.97 (0.91)

No Advanced
EHRs
(n = 731616)
Mean (SD)
n (%)
49.4 (27.7)
1.62 (0.88)
1.95 (0.91)

Advanced EHRs
(n = 301289)
Mean (SD)
n (%)

p-value

Adverse drug events
Medicaid
Medicare
Private insurance
Other ins/self pay/no
charge
Neonatal/maternal admit
Transfer into hospital
Race/Ethnicity
White
Black
Hispanic
Other/missing
Teaching hospital
Urban hospital
Small hospital
Medium hospital
Large hospital
Northeastern United
States
Midwestern United States
Western United States
Southern United States

67,724 (6.6)
215,441 (20.9)
380,804 (36.9)
343,188 (33.3)
91,350 (8.9)

48,772 (6.7)
149,105 (20.4)
281,521 (38.5)
237,420 (32.5)
62,332 (8.5)

18,952 (6.3)
66,338 (22.1)
99,283 (33.1)
105,768 (35.2)
29,018 (9.7)

<0.0001
<0.0001

235,592 (22.8)
56,766 (5.5)

162,799 (22.3)
35,497 (4.9)

72,793 (24.2)
21,269 (7.1)

<0.0001
<0.0001

591,032 (57.2)
117,404 (11.4)
124,379 (12.0)
200,086 (12.0)
504,828 (48.9)
930,479 (90.1)
116,715 (11.3)
248,545 (24.1)
667,645 (64.6)
281,526 (27.3)

433,788 (59.3)
76,097 (10.4)
90,275 (12.3)
131,452 (18.0)
310,797 (42.5)
639,567 (87.4)
93,943 (12.8)
170,981 (23.4)
466,692 (63.8)
166,609 (22.8)

157,244 (52.2)
41,307 (13.7)
34,104 (11.3)
68,634 (22.8)
194,031 (64.4)
290,912 (96.6)
22,772 (7.6)
77,564 (25.7)
200,953 (66.7)
114,917 (38.1)

<0.0001

133,327 (12.9)
295,064 (28.6)
322,988 (31.3)

72,746 (9.9)
22,9429 (31.4)
262,832 (35.9)

60,581 (20.1)
65,635 (21.8)
60,156 (20.0)

45.9 (28.0)
1.57 (0.87)
1.97 (0.91)

<0.0001
<0.0001
<0.0001

<0.0001
<0.0001
<0.0001

<0.0001
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Table 4. Zero-Inflated Poisson Parameter Estimates
Variable
Advanced EHRs
Age
Female
Race
Black
Hispanic
Other/unknown
White (ref)
Risk mortality
Risk severity
Neonatal or maternal admit
Teaching hospital
Hospital’s number of beds
Urban vs. Rural location
Insurance
Medicaid
Medicare
Other insurance/self-pay/no charge
Private
Geographic Region
Midwest
Northeast
South
West
Transferred into hospital
Case Mix
Propensity strata

Poisson
95% CI
-0.0052, 0.0242
-0.0105, -0.0096
0.0656, 0.0911

P
0.2058
<0.0001
<0.0001

Binomial (Probability of zero medication errors)
Estimate
95% CI
p
0.0045
0.0273, 0.0637
<0.0001
-0.0008
-0.0013, -0.0002
0.0051
-0.0434
-0.0593, -0.0275
<0.0001

-0.5211
-0.3660
-0.2649
Ref
-0.0059
0.0617
-0.6434
0.0871
-0.0049
0.1574

-0.5466, -0.4957
-0.3930, -0.3390
-0.2870, -0.2427

<0.0001
<0.0001
<0.0001

-0.3960
0.0840
-0.1527

-0.4304, -0.3617
0.0521, 0.1160,
-0.1803, -0.1250

<0.0001
<0.0001
<0.0001

-0.0164, 0.0047
0.0502, 0.0732
-0.6886, -0.5982
0.0677, 0.1065
-0.0161, 0.0062
0.1272, 0.1876

0.2744
<0.0001
<0.0001
<0.001
0.3841
<0.0001

-0.1992
-0.4464
1.4943
0.1579
0.0450
0.1052

-0.2128, -0.1855
-0.4603, -0.4325
1.4482, 1.5404
0.1336, 0.1822
0.0311, 0.0589
0.0672, 0.1432

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

0.0093
0.0217
0.0548
Ref

-0.0109, 0.0295
0.0038, 0.0397
0.0315, 0.0780

0.3669
0.0178
<0.0001

-0.1367
0.0690
-0.1392

-0.1610, -0.1124
-0.0912, -0.0467
-0.1671, -0.1112

<0.0001
<0.0001
<0.0001

0.0999
-0.0197
-0.0763
Ref
0.0399
-0.0138
-0.0695

0.0689, 0.1309
-0.0466, 0.0072
-0.0942, -0.0584

<0.001
0.1515
<0.0001

-0.1725
0.0760
-0.0178

-0.2114, -0.1336
0.0428, 0.1093
-0.0400, 0.0044

<0.0001
<0.0001
0.1157

0.0215, 0.0582
-0.0169, -0.0107
-0.0826, -0.0563

<0.0001
<0.0001
<0.0001

<0.0001
<0.0001
<0.0001

0.1199, 0.1666
0.0735, 0.0817
-0.0623, -0.0295

<0.0001
<0.0001
<0.0001

Estimate
0.0095
-0.0101
0.0784
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Table 5. Logistic Regression Parameter Estimates
Variable
Advanced EHRs
Age
Female
Race
Black
Hispanic
Other/unknown
White (ref)
Risk mortality
Risk severity
Neonatal or maternal admit
Teaching hospital
Hospital’s number of beds
Urban vs. Rural location
Insurance
Medicaid
Medicare
Other insurance/self-pay/no charge
Private
Geographic Region
Midwest
Northeast
South
West
Transferred into hospital
Case Mix
Propensity strata

Binomial (Probability of medication errors)
Estimate
95% CI
P
-0.0291
-0.0378, -0.0205
<0.0001
-0.0077
-0.0079, -0.0075
<0.0001
0.1081
0.1006, 0.1155
<0.0001
-0.1545
-0.3871
-0.0992
Ref
0.1368
0.4214
-1.9713
-0.0494
-0.0366
0.0590

-0.1669, -0.1422
0.4015, 0.3726
-0.1110, -0.0874

<0.0001
<0.0001
<0.001

0.1306, 0.1429
0.4150, 0.4278
-1.9919, -.1.9506
-0.0606, -0.0382
-0.0428, -0.0303
0.0424, 0.0757

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

0.1238
0.0720
0.1527
Ref

0.1116, 0.1360
0.0614, 0,0826
0.1386, 0.1668

<0.0001
<0.0001
<0.0001

0.3385
-0.0828
-0.0515
Ref
-0.0863
-0.0785
-0;.0257

0.2108, 0.2462
-0.0982, -0.0675
-0.0619, -0.0411

<0.0001
<0.0001
<0.0001

-0.0969, -0.0757
-0.0810, -0.0761
-0.0331, -0.0i83

<0.0001
<0.0001
<0.0001
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Table 6. Base Estimate Propensity Strata and Matched Sample Proportions of
Medication Errors Among Hospitals with and without Advanced EHR
(Logistic Regression Model)
Base Estimate Propensity
Strata (n=1,032,905)
Advance EHR
No Advanced EHR
Difference

*p<0.05

0.039
0.040
0.01*

Base Estimate Propensity
Matched Sample
(n=61,390)
0.037
0.036
-0.01
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Table 7. NPSF Recommendations for Achieving a Total Systems Approach and
Culture of Safety
1.

Ensure that leaders establish and sustain a safety culture.

2.

Create centralized and coordinated oversight of patient safety.

3.

Create a common set of metrics that reflect meaningful outcomes.

4.

Increase funding for research in patient safety and implementation science.

5.

Address safety across the entire care continuum.

6.

Support the health care workforce.

7.

Partner with patients and families for the safest care.

8.

Ensure that technology is safe and optimized to improve patient safety.

Source: NPSF (2015)
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FIGURES
Figure 1. Standardized Mean Differences Plot
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APPENDIX: ADDITIONAL DESCRIPTIVE SUMMARIES

Regional Distribution of Advanced EHRs

Regional Distribution of Advanced EHR
50.0%

45.4%

45.0%

40.8%

40.0%
Percent (%)

35.0%
30.0%
22.2%

25.0%

18.6%

20.0%
15.0%
10.0%
5.0%
0.0%
MW

NE
South
Geographical Region

West

90

Types of Medication Errors

80%

Percent of Patient Cases with >=1
Medication Error by Category*

70.7%

70%

Percent (%)

60%
50%
40%
30%

24.3%

20%

11.8%

10%
0%
Clinical side effects

Poisonings

Adverse effects

Medication Error Category

*Note: Percentage of admissions (or patient cases) with medication errors
falling within each category. Categories are not mutually exclusive. Each
patient case may have multiple types of medication error.
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Types of Medication Errors by Age

Age Distribution of Patient Cases with
Medication Errors
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Types of Medication Errors by Race

Racial/Ethnic Distribution of
Medication Errors
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Types of Medication Errors by Primary Insurance Status
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Types of Medication Errors by Hospital Size
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Types of Medication Errors by Region

Regional Distribution of Medication Errors
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